Sigma Receptors Modulation of Voltage-gated Ion Channels in Rat Autonomic Neurons by Zhang, Hongling
University of South Florida
Scholar Commons
Graduate Theses and Dissertations Graduate School
7-22-2005
Sigma Receptors Modulation of Voltage-gated Ion
Channels in Rat Autonomic Neurons
Hongling Zhang
University of South Florida
Follow this and additional works at: https://scholarcommons.usf.edu/etd
Part of the American Studies Commons
This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in
Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact
scholarcommons@usf.edu.
Scholar Commons Citation
Zhang, Hongling, "Sigma Receptors Modulation of Voltage-gated Ion Channels in Rat Autonomic Neurons" (2005). Graduate Theses
and Dissertations.
https://scholarcommons.usf.edu/etd/930
  
 
Sigma Receptors Modulation of Voltage-gated Ion  
Channels in Rat Autonomic Neurons 
 
 
 
by 
 
 
 
Hongling Zhang 
 
 
 
 
 
A dissertation submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
Department of Pharmacology and Therapeutics 
College of Medicine 
University of South Florida 
 
 
 
 
 
Co-major Professor: Javier Cuevas, Ph.D. 
Co-major Professor: Lynn Wecker, Ph.D. 
Craig Doupnik, Ph.D. 
Jahanshah Amin, Ph.D. 
Keith Pennypacker, Ph.D. 
 
 
 
Date of Approval: 
July 22, 2005 
 
 
 
Keywords: Calcium Channel, Potassium Channel, Sodium Channel 
 
© Copyright 2005, Hongling Zhang
  
 
 
 
ACKNOWLEDGEMENTS 
 
 I would like to express my gratitude and appreciation to my mentor, Dr. 
Javier Cuevas, for his support, patience and encouragement throughout my 
graduate studies.  His technical and editorial advice was essential to the 
completion of this dissertation.  I would also like to thank my external reviewer, 
Dr. Wayne Bowen, for taking the time to read this dissertation and offering 
constructive comments.  My thanks also go to my co-major professor, Dr. Lynn 
Wecker, and my committee: Drs. Jahanshah Amin, Craig Doupnik and Keith 
Pennypacker for providing many valuable comments that improved the contents 
and the presentation of this dissertation. 
 I would like to thank Dr. Wayne Dehaven for his generous help in the 
experiments and excellent advices in writing this dissertation.  I would also like to 
thank Crystal Reed and Yolmari Cruz for maintaining the laboratory  
 Last, but not least, I would like to give my special thanks to my husband, 
Xiaoyu Mei, for his love and understanding and my dear daughter, Hannah, for 
her shining smile that let me feel I am the happiest mom in the world.  I would 
also like to thank my parents for their life-long love and my parents-in-law for 
their love, encouragements and support. 
  
 The research in this dissertation has been supported in part by the 
American Heart predoctoral fellowship. 
 
  i
 
 
 
TABLE OF CONTENTS 
 
List of Tables 
 
……………………………………………………………………. 
 
iv
List of Figures 
 
…………………………………………………………………..
 
v
Abstract 
 
………………………………………………………………………….. 
 
viii
Chapter 1 Background and Significance    ………………………………...... 1
 Sigma receptors    ..........................……………………………………… 1
 Sigma receptors in cardiovascular system    …………………………… 5
 Sigma receptors in autonomic neurons    ………………………….…… 7
 Sigma receptors modulation on voltage-gated ion channels    ……..... 8
 Biomedical significance    ………………………………………………… 
 
9
Chapter 2 
 
Sigma receptors modulation on high-voltage-activated calcium 
channels in rat sympathetic and parasympathetic neurons    … 11
 Introduction    ………………………………………………………………. 11
 Methods    ………………………………………………………………….. 14
 Preparation and electrical recording    …………..………………… 14
 RT-PCR    …………………………………………………………….. 16
 Solutions and reagents    …………………...………………………. 18
 Results    …………………………………………………………………… 20
 Sigma receptor-mediated attenuation of Ca2+ channels currents 21
 Concentration-dependent inhibition of IBa by sigma ligands    ….. 22
  ii
 Sigma receptor antagonist depresses the effect of DTG on Ca2+ 
channels    ……………………………………………………………. 23
 Sigma receptors inhibit Ca2+ channels in parasympathetic 
neurons    …………………………………………………………….. 24
 Effects of haloperidol on Ca2+ channel inactivation   ……………. 25
 Effects of haloperidol on the voltage dependence of Ca2+ 
channel activation    …………………………………………………. 27
 Effect of intracellular dialysis with GTP and GDP-β-S on sigma 
receptor inhibition of IBa    …………………………………………... 28
 Discussion    ……………………………………………………………….. 
 
46
Chapter 3 Sigma receptor activation blocks potassium channels and 
depresses neuroexcitability in rat intracardiac neurons    ...…... 55
 Introduction    ………………………………………………………………. 55
 Methods    …………………………………………………………………..   59
 Preparation of cell culture    ……...………..……………………….. 59
 Electrical recordings    ………………………………………………. 59
 Data analysis    ...............................……………………………….. 61
 Solutions and reagents    …………………………………………… 61
 Results    …………………………………………………………………… 63
 Sigma receptors activation inhibit delayed outward rectifying K+ 
currents    …………………………………………………………….. 63
 Concentration-dependent inhibition of IK(DR) by sigma ligands    .. 64
 The sigma receptor antagonist, metaphit, depresses the effect 
of DTG on K+ channels    …………………………………………… 65
 Effect of intracellular dialysis with GTP and GDP-β-S on sigma 
receptor inhibition of IK(DR)    ………………………………………... 66
 Effects of sigma receptor ligands on action potential firing    …… 67
 Role of M-current in the effects of sigma receptor activation    … 68
  iii
 Effects of sigma receptor activation on BK currents    …………... 69
 
 
Discussion    ……………………………………………………………….. 
 
83
Chapter 4 Sigma receptors activation inhibits voltage-gated sodium 
channels in rat intracardiac neurons    ....................................... 89
 Introduction    ………………………………………………………………. 89
 Methods    ………………………………………………………………….. 92
 Preparation of Cell culture    ……………………………………….. 92
 Electrical recording    ………………………………………………... 92
 Solutions and Reagents     …………………………………………. 93
 Data analysis    ………………………………………………………. 94
 Results    …………………………………………………………………… 95
 Sigma receptor activation inhibits voltage-gated Na+ channels     95
 Concentration-dependent inhibition of INa by sigma ligands    ..... 96
 Effects of sigma receptor activation on voltage-gated Na+ 
channel inactivation    ………………………………………………. 97
 Effects of sigma receptors on the latency of AP generation    ….. 98
 
 
Discussion    ……………………………………………………………….. 
 
111
Chapter 5 Summary    …………………………………………………………. 117
 
 
Conclusion    ……………………………………………………….. 
 
124
Works Cited 
 
……………………………………………………………………... 128
About the Author ……………………………………………………….. End Page
  iv
 
 
 
LIST OF TABLES 
 
Table 3.1 Effects of sigma ligands on the resting membrane potential 
and AP waveform parameters    .......................................... 82
Table 5.1 IC50 values of (+)-pentazocine and ibogaine on voltage-
gated Ca2+, K+ and Na+ channels    ..................................... 125
  v
 
 
 
LIST OF FIGURES 
 
Figure 2.1 Detection of sigma-1 receptor transcripts in rat intracardiac 
and superior cervical ganglia    …………………………...……...
 
31
Figure 2.2 Inhibition of Ca2+ channel currents in sympathetic neurons by 
the sigma receptor agonist, haloperidol    …………………........
 
32
Figure 2.3 Dose-dependent inhibition of depolarization-activated Ca2+ 
channels by sigma receptor ligands in rat sympathetic 
neurons    …………………………………………………………...
 
34
Figure 2.4 Reversibility of DTG-induced block of depolarization-activated 
Ca2+ channels    ……………………………………….................. 
 
36
Figure 2.5 Attenuation of DTG-mediated inhibition of Ca2+ channels by 
the sigma receptor antagonist, metaphit    ……………………...
 
38
Figure 2.6 Inhibition of Ca2+ channel currents in rat intracardiac neurons 
by sigma receptor ligands    ………………………………….….. 
 
40
Figure 2.7 Sigma receptor modulation of time-dependent and steady-
state inactivation of Ca2+ channels in SCG neurons    ………...
 
42
  
  vi
Figure 2.8 Sigma receptor evoked shift in voltage dependence of Ca2+ 
channel activation    ………………………………………………. 
 
44
Figure 2.9 Sigma receptor inhibition of Ca2+ channels is not blocked by 
intracellular GDP-β-S    .............................................................
 
45
Figure 3.1 The sigma receptor ligands inhibit IK(DR) in rat intracardiac 
neurons    …………………………………………………………...
 
71
Figure 3.2 Dose-dependent inhibition of IK(DR) by sigma receptor ligands 
in rat intracardiac neurons    ……………………………..............
 
73
Figure 3.3 Attenuation of DTG-mediated inhibition of IK(DR) by the sigma 
receptor antagonist metaphit    …………………………............. 
 
74
Figure 3.4 The sigma receptor inhibition of IK(DR) is not blocked by 
intracellular GDP-β-S    ……………………………………………
 
76
Figure 3.5 Inhibition of action potential firing by sigma receptor ligand 
DTG in rat intracardiac neurons    ………………………………. 
 
77
Figure 3.6 The sigma receptor ligand DTG inhibits the M-current in rat 
intracardiac neurons    ……………………………………………. 
 
79
Figure 3.7 The sigma receptor activation blocks BK in rat intracardiac 
neurons    …………………………………………………………...
 
81
Figure 4.1 Inhibition of Na+ channel currents in rat ICG neurons by the 
sigma receptor agonist, DTG    ………………………………….. 100
  vii
 
Figure 4.2 Dose-dependant inhibitions of depolarization-activated Na+ 
channel currents by sigma receptors agonists in rat ICG 
neurons    …………………………………………………………...
 
102
Figure 4.3 Dose-dependant inhibitions of depolarization-activated Na+ 
channel currents by sigma receptors partial agonist, BD1047 
in rat ICG neurons    ……………………………………………….
 
104
Figure 4.4 Reversibility of DTG-induced block of voltage-gated Na+ 
channels    …………………………………………………………. 
 
106
Figure 4.5 Sigma receptor modulation of steady-state inactivation of Na+ 
channels in rat ICG neurons    …………………………………... 
 
108
Figure 4.6 Sigma receptors ligands increased the latency of AP (AP) 
generation in rat ICG neurons    ………………………………….
 
110
  viii
 
 
Sigma Receptors Modulation of Voltage-gated Ion  
Channels in Rat Autonomic Neurons 
 
Hongling Zhang 
 
 
ABSTRACT 
 
  Sigma receptors have been implicated in the regulation of the 
cardiovascular system.  Some of the cardiovascular effects of sigma receptors 
may be through the modulation of autonomic neurons.  Studies on the 
expression and cellular function of sigma receptors in autonomic neurons were 
conducted in neonatal rat intracardiac (ICG) and superior cervical ganglia (SCG).   
 Individual neurons from SCG and ICG were shown to express transcripts 
encoding the sigma-1 receptor.  The effects of sigma receptors activation on 
high-voltage-activated Ca2+ channels was studied in isolated neurons of these 
ganglia.  Bath application of sigma receptor agonists depressed peak calcium 
channel currents in a dose-dependent manner and the rank order potency of 
haloperidol> ibogaine > (+)-pentazocine > DTG is consistent with the effects 
being mediated by a sigma-2 receptor.   Sigma receptor antagonist, metaphit, 
blocked DTG-mediated inhibition of Ca2+ current. Sigma ligands also altered the 
biophysical properties of these channels. 
  ix
 Activation of sigma receptors reversibly blocked delayed outwardly 
rectifying potassium channels, large conductance Ca2+-sensitive K+ channels, 
and the M-current with maximal inhibition >80%.  The rank order potency of 
different sigma ligands suggests that the effect is mediated by sigma-1 receptor.  
While bath application of sigma ligands depolarized ICG neurons, the number of 
action potentials (AP) fired by the cells in response to depolarizing current pulses 
was decreased.  Experiments on the signal transduction cascade mediated the 
inhibition of K+ and Ca2+ channels by sigma ligands showed that the signal 
transduction pathway does not involve a diffusible cytosolic second messenger 
or a G-protein.   
 Sigma ligands also modulate voltage-gated Na+ channels (VGSC) in ICG 
neurons.  Bath application of sigma ligands inhibited VGSC current with maximal 
inhibition >90% and altered the biophysical properties of VGSC. The latency of 
AP generation during depolarizing current ramp was increased by sigma ligands 
and this effect is through the inhibition of VGSC. 
 These data suggest that activation of sigma receptors on autonomic 
neurons modulates voltage-gated Ca2+, K+ and Na+ channels and as a result, the 
generation of AP is inhibited in these neurons. Sigma receptors are likely altering 
the cell-to-cell signaling in autonomic ganglia and thus regulating cardiac function 
by the peripheral nervous system. 
  1
 
 
 
CHAPTER 1 
BACKGROUND AND SIGNIFICANCE 
 
SIGMA RECEPTORS 
  Sigma receptors were postulated in 1976 by Martin et al based upon the 
actions of the benzomorphan opiate SKF-10,047 and were originally thought to 
be a type of opiate receptor (Martin et al., 1976).  Two subsequent findings 
convincingly demonstrated that sigma receptors are not members of the opiate 
receptor family.  First, the enantioselectivity for the ligands is different: opiate 
receptors are selective for the (-) isomers of opium-derived narcotics, narcotic 
antagonists, and their congeners.  Sigma receptors are enantioselective for the 
(+) isomers.  Second, traditional opiate receptors antagonists such as naloxone 
or naltrexone are ineffective against both the in vivo and the in vitro effects of 
sigma ligands (Brady et al., 1982; Iwamoto, 1981; Katz et al., 1985; Slifer and 
Balster, 1983; vaupel, 1983).  Therefore, the sites defined as sigma today are not 
opioid and represent a unique type of receptor. 
 Given that SKF10,047 and phencyclidine (PCP) produce many of the 
same psychotomimetic effects, some investigators proposed a common receptor 
for the two, called the sigma/PCP site (Zukin et al., 1984).  Further analysis later 
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revealed that the two sites are separate and show different localization across 
brain area.  The sigma site has high affinity for SKF10,047, lower affinity for PCP, 
and is also sensitive to low concentrations of haloperidol.  In contrast, the PCP 
site has high affinity for PCP, lower affinity for SKF10,047, and is insensitive to 
low concentration of haloperidol.  It is now well established that the sigma site 
represent a unique binding site in mammalian brain and peripheral organs, 
distinct from any other known transmitter receptors (Walker et al., 1990). 
At least two subtypes of sigma receptor have been classified based on the 
findings from biochemical and radioligand binding experiments and have been 
designated as sigma-1 and sigma-2.  The sigma-1 site was suggested for the 
guinea pig brain traditional sigma while sigma-2 was rat pheochromocytoma 
(PC12) cell sigma-like sites, respectively (Hellewell and Bowen, 1990; Quirion et 
al., 1992).  Only sigma-1 receptor has been cloned and in human, sigma-1 gene 
is located on chromosome 9p13, a region associated with psychiatric disorders 
(Prasad et al., 1998).  The structure of the sigma-1 receptors showed no 
homology with other known mammalian protein, but possessed some homology 
with fungal sterol isomerases (Hanner et al., 1996; Kekuda et al., 1996; Seth et 
al., 1998).  The cDNA of sigma-1 receptor predicted a protein of 223 amino acids 
and the molecular weight is 25 KDa.  Initial hydropathy analysis of the deduced 
amino acid sequence of sigma-1 receptor suggested a single putative 
transmembrane domain, which played a critical role in ligand binding of this 
receptor (Prasad., 1998; Yamamoto et al., 1999).  Subsequently, when 
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expressed in Xenopus lavis oocytes, the domain accessibility experiments 
suggested that sigma-1 receptor has two membrane-spanning segments, with 
the NH2 and COOH termini on the cytopalsmic side of the membrane (Aydar et 
al., 2002).  In this model, the proposed ligand binding domain is located in the 
COOH-terminus intracellular portion. 
In the oocyte, guinea pig sigma-1 receptor was found mainly in the plasma 
membrane (Aydar et al., 2002), however, it has been found that at N-terminus, 
there was an endoplasmic reticulum retention signal motif, suggests that sigma-1 
receptor exists not only in the plasma membrane but also in intracellular 
membranes, which makes it different from conventional neurotransmitter 
receptors (Kekuda et al., 1996; Hanner et al., 1996). 
The molecular nature of sigma-2 receptor is still unknown and it has been 
presumed that sigma-2 receptor gene encodes a protein of Mr 21,500.  In both 
mice and humans, it has been suggested that the splicing variants of the sigma-1 
receptor gene could display sigma-2 receptor binding activities (Monassier and 
Bousquet, 2002).  However, in the sigma-1 receptor knockout mouse, sigma-2 
receptor binding sites have no changes compared with the wild type mouse, 
suggesting that sigma-1 and sigma-2 are not two isoforms of the same protein 
(Langa et al., 2003).  Similar to sigma-1 receptor, some studies also showed that 
sigma-2 receptors are intracellular receptors located in the membranes of the 
endoplasmic reticulum and mitochondria (Bowen 2000). 
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Sigma-1 and sigma-2 receptor exhibits a distinct pharmacological profile.  
Sigma-1 receptors display high affinity for (+)-pentazocine, (+)-SKF-10,047 and 
other (+)-benzomorphans, whereas sigma-2 receptors have low affinity for these 
compounds but have high affinity for ibogaine (Hellewell and Bowen, 1990; 
Hellewell et al., 1994; Bowen et al., 1995). 
Since originally proposed, sigma receptors have been observed across 
many species and are present at high levels in CNS, immune system, liver and 
kidney.  (Wolfe and De Souza, 1992; Hellewell et al., 1994)  Although the 
function of these receptors is not well understood, sigma receptors have been 
implicated in the modulation of various biochemical, behavior and physiological 
processes (Walker et al., 1990).  In the central nervous systems, sigma receptors 
are concentrated in brainstem areas that regulate motor function, limbic 
structures, some predominantly sensor areas and areas associated with 
endocrine function.  Sigma receptors have been implicated not only in the 
regulation of posture and motor activity (Glodstein et al., 1989, Bowen et al., 
1988), but also in the modulation of opioid analgesia (King et al., 1997), cocaine-
induced toxicity (McCracken et al., 1999), learning and memory (Maurice et al., 
1998), drug abuse (Maurice et al., 2003), neuroprotection in cerebral ischemia 
(Takahashi et al., 1996; Lockhart et al., 1995; Goyagi et al., 2001), as well as in 
regulation of neurotransmitter release and modulation of neurotransmitter 
receptor function (Matsuno et al., 1993; Couture and Debonnel, 1998; Patrik et 
al., 1993). 
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It was also found that both subtypes of sigma receptors are expressed in 
very high density in tumor cell lines derived from various tissues, which suggests 
important cellular functions of sigma receptors in cancer and potential diagnostic 
utility for tumor imaging agents which target sigma binding sites (Vilner et al., 
1995; Brent and Pang 1995; Barbieri et al., 2003).  Thus, it is likely that sigma 
receptors have important functions outside of the nervous system and may serve 
a more general role than a neurotransmitter receptor. 
 Although there is evidence for the existence of sigma receptor binding 
sites in brain and tissue extracts, no endogenous functional ligand for sigma 
receptors has been conclusively identified.  Various candidates have been 
suggested, such as, progesterone (Su et al., 1988), Neuropeptide Y (NPY), 
peptide YY (Roman et al., 1989) and zinc (Connor and Chavkin, 1992).  These 
data suggest that sigma-binding sites constitute a true receptor that binds to 
endogenous ligands released in response to neurostimulation. 
    
SIGMA RECEPTORS IN CARDIOVASCULAR SYSTEM 
Much of the initial interest in sigma receptors was driven by their potential 
role in the actions of antipsychotic drug.  This was due mainly to their high affinity 
for most of the typical neuroleptics, such as haloperidol and their shared affinity 
for compounds known to cause psychotomimetic activity such as N-
allylnormetazocine (SKF10,047) (Su, 1982; Tam and Cook, 1984).  Sigma 
receptors are also found in high density in many tissues outside of the central 
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nervous system, such as, endocrine, immune, and gastric system (see Walker et 
al., 1990).  Sigma binding sites have been detected in cardiac myocytes from 
neonatal and adult rats (Ela et al., 1994; Novakova et al., 1995).  In neonatal rat 
cardiac myocytes, sigma receptor ligands, at nanomolar concentrations, exert a 
complex effect on the amplitudes and frequencies of contraction, Ca2+ fluxes and 
[Ca2+]I transients (Ela et al., 1994).  Pretreatment of these cells with sigma 
ligands caused the desensitization of the receptor (Ela et al., 1996).  However, 
sigma ligands, at concentrations of 10 nM and higher, markedly increased the 
amplitude of systolic cell contraction and the amplitudes of [Ca2+]I transients in 
adult rat cardiac myocytes (Novakova et al., 1995).  These effects were shown to 
be mediated by elevated production of inositol 1,4,5-trisphosphate (IP3) and 
potentiation of the systolic release of Ca2+ from sarcoplasmic reticulum-Ca2+ 
stores. 
 It has been shown that sigma receptor antagonist DuP 734 increase the 
heart tolerance to ischemic and reperfusion arrhythmias both in vivo and in vitro 
(Lishmanov et al., 2000a).  Conversely, the sigma receptor agonists (+)-SKF-
10,047, 1,3-di-O-tolyguanidin (DTG), and (+)-3-[3-hydroxyphenyl]-N-(1- 
propyl)piperidine have been shown to produce tachycardia by activating central 
and peripheral sigma receptors (Wu and Martin, 1989; Lishmanov et al., 2000b).  
Clinical study has also been shown that some psychiatric patients during therapy 
with haloperidol, which is deemed as sigma-1 receptor antagonist and sigma-2 
receptor agonist, tend to have cardiac side effects such as arrhythmia, 
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tachycardia and sudden cardiac death (Settle and Ayd, 1983; Mehta, 1979; 
Turbott et al., 1984).  While the effects of sigma ligands in cardiac muscle may 
be involved in the cardiovascular effects of these agents, very little is known 
about sigma receptors in autonomic neurons that innervate the heart and 
regulate cardiovascular function.  
 
SIGMA RECEPTORS IN AUTONOMIC NEURONS 
 Some evidence does exist that suggests that sigma receptors play an 
important role in the function of peripheral neurons.  For example, sigma 
receptors have been shown to block contractions of longitudinal muscle elicited 
by both electrical stimulus or by exogenous serotonin in the guinea pig 
ileum/myenteric plexus preparation via inhibition of acetylcholine release from 
myenteric neurons (Campbell et al., 1989).  Conversely, sigma receptors 
potentiate neurogenic twitch contraction in the mouse vas deferens by inhibiting 
K+ channels in sympathetic neurons for the hypogastric ganglion, which increase 
norepinephrine release from these cells (Campbell et al., 1987).  Both sigma-1 
and sigma-2 receptors have been detected in rat pheochromocytoma (PC12) 
which exhibit a phenotype similar to sympathetic neurons and sigma-2 receptors 
were shown to enhance amphetamine-stimulated dopamine release from these 
cells (Hellewell and Bowen, 1990; Sagi et al., 1996; Weatherspoon and Werling, 
1999). 
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SIGMA RECEPTORS MODULATION ON VOLTAGE-GATED ION CHANNELS 
 The effects of sigma receptor ligands on voltage-gated ion channels have 
been investigated in several types of cells, and K+ channels are the most 
extensively studied.  In frog pituitary melanotrophs, for example, sigma receptors 
activation increased electrical activity by inhibiting K+ currents via activation of a 
cholera toxin-sensitive G protein; even though sigma receptors share no 
homology with classic G-protein coupled receptors (Soriani et al., 1998; Soriani 
et al., 1999a).  Conversely, in rat neurohypophysial terminals, neither G-protein 
nor any soluble cytoplasmic factor were involved in the modulation of K+ 
channels by pentazocine or (+)SKF10047 (Lupardus et al., 2000).  Aydar et al 
reconstituted sigma-1 receptor modulation of Kv1.4 and Kv1.5 in oocytes by 
heterologous expression of the K+ channels with sigma-1 receptors.  It was found 
that (+)SKF10047 depressed K+ current only in the oocytes that injected with 
both sigma-1 receptors and K+ channel subunits and it was also showed that the 
sigma-1 receptor alters the kinetic properties of Kv1.4 channel in the absence of 
sigma ligands (Aydar et al.,2002).  These findings together with the observation 
that sigma-1 receptor forms an immunoprecipitating complex with K+ channels 
both in rat neurohypophysis and when coexpressed in oocytes, led investigators 
to propose that the sigma receptor functions as a ligand-regulated auxiliary K+ 
channel subunit (Aydar et al., 2002).  These studies have made advances in 
deducing the mechanisms of the signal transduction pathway of the ion channel 
modulation. 
  9
 Ion channels are expressed in several types of tumor cells and play an 
important role in metastasis, an integral aspect of which is the control of cell 
growth and proliferation.  For example, down-regulation of K+ channel amplitude 
has been associated with the metastatic phenotype in human breast and prostate 
cancer (Wonderlin and Strobl, 1996; Fraser et al., 2003) and voltage-gated Na+ 
channels are also involved in the metastatic cascade in prostate cancer (Fraser 
et al., 2003).  In DMS-114 cells (a tumor cell line derived from human small cell 
lung carcinoma), sigma receptors are highly expressed and sigma ligands have 
been shown to inhibit voltage-gated K+ channel currents (Wilke et al., 1999).  
Because both subtypes of sigma receptors are expressed in very high density in 
tumor cell lines (Vilner et al., 1995; Brent and Pang., 1995; Barbieri et al., 2003) 
and sigma-1 receptors functions as a auxiliary K+ channel subunit, it raises the 
possibility that sigma receptor ligands could be useful as novel anti-cancer 
agents (Adyar et al., 2002). 
 
BIOMEDICAL SIGNIFICANCE 
 It has been suggested that sigma receptors may regulate the 
cardiovascular system (Ela et al., 1994) and direct effects of sigma ligands on 
cardiac muscle have been documented, very little is known about sigma 
receptors in autonomic neurons that innervate the heart.  The presence of 
putative endogenous ligands of sigma receptors, including neuropeptide Y 
(Roman et al., 1989) and substance P (Larson and Sun 1993), in these ganglia 
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(Hassall and Burnstock 1984; Karhula 1995; Kessler and Black 1982; Papka et 
al., 1981) suggests that sigma receptors may be activated under physiological 
conditions, affecting cell-to-cell signaling in the ganglia, and ultimately the 
regulation of cardiac functions by the autonomic nervous system.  It is also 
known that drugs of abuse, such as cocaine and PCP, have high binding affinity 
with sigma receptors, and their cardiovascular side effects may be due to the 
activation of sigma receptors in autonomic neurons. 
 Current studies on the modulation of voltage-gated ion channels by sigma 
receptors of autonomic neurons will not only serve to increase our understanding 
of the functions of these receptors in the heart but also on the cellular functions 
of these poorly understood receptors. 
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CHAPTER 2 
SIGMA RECEPTORS MODULATION ON HIGH-VOLTAGE-ACTIVATED 
CALCIUM CHANNELS IN RAT SYMPATHETIC AND PARASYMPATHETIC 
NEURONS 
 
INTRODUCTION 
 
Sigma receptors are widely distributed in mammalian brain and peripheral 
systems and organs.  These receptors have been pharmacologically defined into 
two subclasses of receptors, sigma-1 and sigma-2 (Hellewell and Bowen 1990; 
Quirion et al., 1992), with a major difference being the higher affinity of sigma-1 
receptors for (+) pentazocine (Quirion et al., 1992) and the greater affinity of 
sigma-2 receptors for ibogaine (Bowen et al., 1995).  While only the sigma-1 
receptor has been cloned, studies using photolabeling techniques with sigma 
ligands on guinea pig brain and PC12 cell membranes suggest that distinct 
molecular entities exist that correspond to the two sigma receptor subtypes 
(Hellewell and Bowen 1990).  The function of these receptors is not well 
understood; however, sigma receptors have been implicated in the modulation of 
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various biochemical, behavioral, and physiological processes (Walker et al., 
1990).   
It has been suggested that sigma receptors may regulate the 
cardiovascular system (Ela et al., 1994).  Sigma ligand binding sites have been 
detected in cardiac myocytes, and sigma ligands, including (+)-pentazocine and 
haloperidol, have been shown to alter contractility, Ca2+ influx, and contraction 
rate in cultured cardiac myocytes (Ela et al., 1994; Novakova et al., 1995).  
However, while direct effects of sigma ligands on cardiac muscle have been 
documented, very little is known about sigma receptors in autonomic neurons, 
and in particular sympathetic or parasympathetic neurons that innervate the 
heart.   
A process frequently targeted by sigma receptor modulation is intracellular 
calcium homeostasis.  In the human neuroblastoma cell line, SK-N-SH, sigma-2 
receptors have been shown to evoke release of Ca2+ from intracellular stores 
(Vilner and Bowen, 2000).  Studies have also suggested that sigma ligands may 
block Ca2+ channels in hippocampal neurons and vascular smooth muscle 
(Church and Fletcher, 1995; Flaim et al., 1985), although these effects were 
attributed to direct modulation of Ca2+ channels by the sigma ligands.  The effect 
of sigma receptor activation on calcium channels, and in particular calcium 
channels of autonomic neurons, remains to be elucidated.  Regulation of calcium 
channel function is a means by which various neurotransmitters exert their effects 
on autonomic neurons (Jeong et al., 1999).  For example, both neuropeptide Y 
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and norepinephrine depress calcium channel currents in rat ICG neurons (Jeong 
et al., 1999; Xu and Adams 1993).  This inhibition of calcium channels is believed 
to be a mechanism by which the sympathetic nervous system modulates the 
activity of the parasympathetic nervous system.  Similarly, acetylcholine, acting 
via M4 muscarinic receptors, blocks calcium channel currents in intrinsic cardiac 
neurons (Cuevas and Adams 1997).  This phenomenon is likely to represent a 
feedback mechanism in cholinergic parasympathetic neurons.   
Experiments were undertaken to determine whether sigma receptors are 
present in autonomic neurons of the sympathetic superior cervical ganglion 
(SCG) and the parasympathetic intracardiac ganglion (ICG), and whether 
activation of these receptors modulates the biophysical properties of calcium 
channels in these cells.  Results indicate that sigma-1 receptor transcripts are 
expressed by individual autonomic neurons.  Furthermore, sigma receptors were 
shown to depress peak Ca2+ channel currents, increase the rate of Ca2+ channel 
inactivation, and shift the voltage dependence of both steady-state inactivation 
and activation toward more negative potentials.  Pharmacological experiments 
suggest that sigma-2 receptors modulate Ca2+ channels in these cells and that 
these receptors couple to Ca2+ channels via a signal transduction cascade that 
involves neither a diffusible cytosolic second messenger nor a G protein. 
  14
 
 
 
METHODS 
 
Preparation and Electrical Recording  
Modulation of depolarization-activated Ca2+ channels by sigma receptor 
activation was studied in isolated neurons of neonatal rat ICG and SCG.  The 
preparation of cultured neurons of neonatal rats (3-10 day old) and the 
electrophysiological recording methods used here have been previously 
described (Cuevas and Adams, 1994; Cuevas et al., 2000).  For the SCG 
preparation, neonatal rats were killed by inhalation of carbon dioxide; whereas for 
isolation of ICG neurons, rats were killed by decapitation.  All procedures were 
done in accordance with the regulations of the Institutional Animal Care and Use 
Committee.   
Membrane currents in autonomic neurons, cultured for 24-72 h, were 
studied under voltage-clamp mode using the whole cell recording configuration of 
the patch-clamp technique (Hamill et al., 1981).  Electrical access was achieved 
through the use of the amphotericin B perforated-patch method (Rae et al., 1991) 
to preserve the intracellular integrity of the neurons and prevent calcium current 
rundown (Xu and Adams, 1992).  For perforated-patch experiments, a stock 
solution of amphotericin B (60 mg/ml) in dimethylsulphoxide (DMSO) was 
 prepared and diluted in pipette solution immediately prior to use to yield a final 
concentration of 198 µg/ml amphotericin B in 0.33% DMSO.  Final patch pipette 
resistance was 1.0-1.3 MΩ to permit maximal electrical access under the present 
recording configuration.  Junction potentials generated by the ions in the pipette 
and bath solutions were compensated for via the Pipette Offset control of the 
Axopatch 200B.  To test for amphotericin B incorporation into the membrane 
patch following gigaseal formation, the neurons were held at 60 mV, and 20-ms 
voltage pulses to 65 mV were applied at 1 Hz.  In successful experiments there 
was an increase in a fast capacitive transient, the appearance of a slow 
capacitive transient, and a decrease in the series resistance (Rs).  To minimize 
voltage error produced by Rs, Rs was monitored throughout the experiment, and 
only cells in which Rs was consistently 3 MΩ following 50% Rs compensation 
were used.  Also, to minimize space-clamp artifact, only cells with no large visible 
processes were selected for the experiments.   
Depolarization-activated Ca2+ channel currents were evoked using voltage 
jumps from 90 mV to more positive potentials.  Capacitive and leak currents 
were subtracted using the P/4 protocol, which assumes a linear relationship for 
these currents at voltages less than 60 mV (Xu and Adams, 1992).  Membrane 
currents were amplified using an Axopatch 200B patch-clamp amplifier (Axon 
Instruments, Union City, CA), filtered at 5 kHz ( 3 dB; 4-pole Bessel filter), and 
digitized at 20 kHz (Digidata 1200B).   
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Ca2+ currents elicited by long (2 s) depolarizations were fit using single or 
double exponential functions and the Clampfit 6.0.5 program (Axon Instruments).  
Activation and steady-state inactivation kinetics were described using Boltzmann 
distributions, and dose-response curves were fit using the Hill equation.  Analysis 
of these data was conducted using the SigmaPlot 2000 program (SPSS Science, 
Chicago, IL).  Data points represent means ± SE.  Statistical difference was 
determined using paired t-test for within-group experiments, and unpaired t-test 
for between groups experiments, and was considered significant if P < 0.05.   
 
RT-PCR 
RT-PCR techniques, similar to those previously reported (Cuevas et al.  
2000), were used for the detection of sigma-1 receptor expression in autonomic 
neurons.  Total RNA was isolated from ICG ganglia and associated tissue and 
from SCG (RNeasy, Qiagen, Hilden, Germany).  RNA was reverse-transcribed in 
a 20-µl reaction volume using the SuperScript First-Strand Synthesis System for 
RT-PCR (Invitrogen, San Diego, CA).  As a negative control, a PCR reaction with 
only water was conducted to eliminate the possibility of false positives due to 
contaminating cDNA.  Primers specific for sigma-1 receptor transcripts were 
designed to span an intron to discriminate between genomic DNA and cDNA.  
The sequences of the primers used were: sigma-1(sense)-
GTCTTTTGCACGCCTCGCTGTCTGAGTACG, sigma-1(antisense)-
ACCCTCTCTGGATGGAGGTGAGTGC, which yielded a product size of 639 
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base pairs.  PCR reactions were conducted using the SuperScript System with 
Platinum Taq DNA polymerase (Invitrogen).  The cycling parameters were one 
cycle of 94°C for 2 min; 30 cycles of 94°C for 30 s, 61°C for 45 s, and 72°C for 1 
min; and 1 cycle of 72°C for 5 min.   
For single-cell RT-PCR experiments, SCG and ICG neurons were 
dissociated, and cytoplasm was extracted from isolated neurons as previously 
described (Poth et al., 1997).  Briefly, the cellular content of individual neurons 
was harvested using the dialyzing whole cell configuration of the patch-clamp 
technique.  The patch pipettes were filled with 3 µl of 1× SuperScript One-Step 
RT-PCR Reaction Mix (Invitrogen) containing 1 U/µl RNAsin (Promega, Madison, 
WI).  Following extraction of the cytoplasm, the content of the pipette was 
expelled into a microfuge tube and quickly frozen on dry ice.  Single-cell RT-PCR 
experiments were conducted immediately following the extraction using 
SuperScript One-Step RT-PCR with Platinum Taq (Invitrogen).  Negative controls 
for these experiments involved suctioning extracellular solution via a patch pipette 
located directly above the cells.  These controls were carried through all 
subsequent reactions to rule out the possibility of contamination from cytoplasm 
from nearby cells or sigma receptor clones isolated in the laboratory.  The cycling 
parameters were 1 cycle of 50°C for 30 min and 95°C for 2 min; 40 cycles of 
94°C for 30 s, 61°C for 45 s, and 72°C for 1 min; and 1 cycle of 72°C for 5 min.  
RT-PCR products were gel purified using a QIAEX II Gel Purification kit 
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(QIAGEN) and sequenced by the Molecular Biology Core Facility at the H.  Lee 
Moffitt Cancer Center and Research Institute.  
  
Solutions and Reagents  
The bath solution used in these experiments was a physiological saline 
solution (PSS) composed of (in mM) 70 NaCl, 70 tetraethylammonium chloride 
(TEA), 5 BaCl2, 1.2 MgCl2, 7.7 glucose, 0.0005 tetrodotoxin (TTX), and 10 
HEPES (pH to 7.2 with NaOH).  Barium was used as the charge carrier to 
maximize Ca2+ channel current amplitude, and to minimize any intracellular Ca2+-
dependent current rundown (Xu and Adams 1992).  All drugs, including sigma 
ligands, were bath applied at room temperature at a rate of ~2 ml/min into a 0.3-
ml recording chamber, which permitted rapid exchange of bath solution.  The 
pipette solution used for perforated-patch experiments contained (in mM) 75 
Cs2SO4, 55 CsCl, 5 MgSO4, and 10 HEPES (pH to 7.2 with N-methyl-d-
glucamine).  Block of ionic current through Ca2+ channels was achieved via bath 
application of 100 µM CdCl2 (Xu and Adams 1992).  For studies using 
conventional (dialyzing) whole cell recording configuration, the pipette solution 
contained (in mM) 140 CsCl, 2 MgCl2, 2 ethylene glycol-bis (β-aminoethyl ether)-
N,N,N',N'-tetraacetic acid (EGTA), 2 Mg2ATP, 0.1 GTP lithium salt (GTP), and 10 
HEPES-CsOH, pH to 7.2 In some experiments GTP was replaced with 100 µM 
guanosine 5'-O-(2-thiodiphosphate) trilithium salt (GDP-β-S) to inhibit G protein 
activation.   
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All chemical reagents used were of analytical grade.  Ibogaine 
hydrochloride, (+)-pentazocine, haloperidol, 1,3-Di-O-tolylguanidine (DTG), 
metaphit, and tetrodotoxin were purchased from Sigma Chemical (St.  Louis, 
MO). 
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RESULTS 
 
To determine whether sympathetic and parasympathetic neurons may be 
the target of sigma receptor ligands, autonomic neurons were first screened for 
the expression of transcripts encoding the sigma-1 receptor using RT-PCR 
techniques.  Oligonucleotide primers were designed to span introns 2 and 3 of 
the sigma-1 gene to differentiate between cDNA and genomic DNA.  RT-PCR of 
total RNA extracts from SCG and ICG ganglia and associated tissue (e.g., 
cardiac myocytes, Schwann cells, and fibroblasts) showed that sigma-1 receptor 
transcripts are expressed in these cells (Figure 1A).  However, since sigma-1 
receptors have been found in nonneuronal cells, it seemed prudent to test for the 
presence of sigma-receptor transcripts at the single-cell level.  Using single-cell 
RT-PCR techniques, transcripts encoding the sigma-1 receptor were shown to be 
expressed in individual ICG and SCG neurons (Figure 1B).  Sigma-1 receptor 
transcripts were detected in 57% of ICG neurons (4 of 7) and 67% of SCG 
neurons (4 of 6).  Sequencing of the products obtained from individual autonomic 
neurons indicated exact sequence homology to the known rat brain sigma-1 
receptor (Seth et al., 1998).  Splice variants of the sigma-1 receptor have been 
reported in the rat and mouse as submissions to GenBank (accession numbers 
 AF087827 and AF226605, respectively).  The oligonucleotide primers used here 
were specifically designed to detect conventional sigma-1 transcripts and both of 
these sequence variants, but no such isoforms were detected in these cells.  
 
Sigma Receptor-Mediated Attenuation of Ca2+ Channel Currents  
Sigma receptors have been shown to modulate calcium homeostasis in 
various cell types.  One of the mechanisms by which sigma receptors appear to 
modulate cellular calcium is through attenuation of calcium influx through the cell 
membrane.  However, the effects of sigma receptor activation on calcium channel 
function have not been determined.   
Ca2+ channel currents were isolated by inhibiting Na+ currents with 
extracellular TTX, and K+ channels with intracellular Cs+ and extracellular TEA 
and Ba2+.  Ba2+ was used as the charge carrier through open calcium channels in 
most experiments for reasons discussed in METHODS.  The effect of sigma 
ligands on the Ba2+ current-voltage (I-V) relationship was examined using brief 
(250ms) step depolarizations of 10-mV increments ( 50 to +90 mV) from a 
holding potential of 90 mV.  Figure 2A shows a family of depolarization-
activated Ba2+ currents (IBa) recorded from a single SCG neuron in the absence 
(Control) and presence of the sigma receptor ligand, haloperidol (10 µM).  Bath 
application of haloperidol depressed peak IBa amplitude at all potentials positive 
to 10 mV within 3 min of drug application.  Figure 2B shows the average I-V 
relationship obtained for six neurons before (Control) and after bath application of 
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 10 µM haloperidol.  Under control conditions, IBa was activated at approximately 
30 mV and the I-V relation was maximal at 0mV, reversing at approximately +50 
mV.  In the presence of haloperidol, the I-V relationship exhibited similar voltage 
dependence, but the peak IBa amplitude was reduced at all voltages.  At 0 mV, IBa 
decreased from a control value of 1,565 ± 76 pA to 969 ± 222 pA in the 
presence of 10 µM haloperidol, (n= 6).  Inhibition of Ca2+ channel currents 
occurred to a similar degree when Ca2+ was the charge carrier (data not shown).   
Bath application of 100 µM Cd2+ completely blocked the depolarization-
activated Ba2+ current, both in the absence and the presence of haloperidol (data 
not shown).  The observed Cd2+ block, coupled with the lack of shift in the 
reversal potential for the depolarization-activated currents (Figure 2B) in the 
presence of sigma ligands, suggests that these drugs are not activating or 
inhibiting another membrane conductance.  
 
Concentration-Dependent Inhibition of IBa by Sigma Ligands  
To determine whether the effect of haloperidol on Ca2+ channels is 
mediated by sigma receptor activation, the ability of various sigma ligands to elicit 
a similar response was assessed.  Figure 3A shows representative currents 
recorded from three different SCG neurons (1-3) in the absence (Control) and 
presence of haloperidol, (+)-pentazocine, and DTG.  The peak inward IBa was 
measured before and after exposure to various concentrations of the sigma 
ligands haloperidol, (+)-pentazocine, DTG, and ibogaine.  For these experiments, 
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each cell was exposed to a minimum of three drug concentrations.  A plot of the 
mean peak IBa as a function of drug concentration is shown in Figure 3B.  
Haloperidol had the greatest potency of the ligands tested, and a fit of the data 
using the Hill equation gave a half-maximal inhibitory concentration (IC50) value 
of 6 µM.  Similarly, the IC50 values for ibogaine, (+)-pentazocine and DTG were 
31, 61, and 133 µM, respectively, and the Hill coefficient was 1.1 for all drugs.  
Maximum inhibition of IBa by all sigma ligands tested was ≥95%.   
The effect of sigma ligands on Ca2+ channel current amplitude was 
reversible on wash out.  Figure 4A shows a family of Ba2+ currents evoked by 
step depolarizations from a single neuron in the absence (Control), presence 
(+DTG), and following wash out for the indicated time points of the sigma ligand, 
DTG.  Following inhibition of IBa, the current recovered to near control levels 
within 5 min of wash out (Figure 4B).  Similar reversal of inhibition was observed 
for all sigma ligands tested here.  No significant rundown of IBa was observed in 
recordings ≤45 min. 
   
Sigma Receptor Antagonist Depresses the Effect of DTG on Ca2+ Channels  
To confirm whether the effect of sigma ligands on Ca2+ channels was 
mediated by activation of a sigma receptor, the irreversible sigma receptor 
antagonist, metaphit was used.  Metaphit is known to rapidly and specifically 
acetylate sigma receptors, which results in a block of ligand binding (Bluth et al., 
1989).  Isolated SCG neurons were preincubated in 50 µM metaphit (in PSS) for 
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10 min at room temperature.  Following wash out of drug, Ba2+ current amplitude 
was similar to that recorded in control experiments (no preincubation; Figure  5A), 
suggesting that preincubation in metaphit alone had no effect on Ca2+ channel 
currents.  On application of DTG, Ba2+ current amplitude was depressed under 
both conditions, but in cells preincubated in metaphit the response to DTG was 
obtunded.  Figure 5B shows a bar graph of relative mean IBa amplitude recorded 
in the presence of 100 µM DTG in control neurons (DTG; n = 7) or neurons 
preincubated in metaphit (Metaphit+DTG; n=6).  DTG decreased mean IBa by 28 
± 4% in cells exposed to metaphit, whereas in control cells the decrease was 49 
± 4%.  The difference in DTG attenuation of IBa under both conditions was 
statistically significant (P<0.01). 
   
Sigma Receptors Inhibit Ca2+ Channels in Parasympathetic Neurons  
To determine whether similar modulation of Ca2+ channels also occurs in 
parasympathetic ICG neurons, the effect of sigma receptor ligands on these 
channels was studied.  For these experiments haloperidol, ibogaine, (+)-
pentazocine, and DTG were used at concentrations near the IC50 value for IBa 
inhibition, as determined in SCG neuron.  Figure 6A shows currents evoked from 
four different neurons in the absence (Control) and presence of the indicated 
sigma ligands.  A plot of the mean inhibition of IBa evoked by these sigma ligands 
is shown in Figure 6B and is consistent with the observations made in SCG 
 neurons.  As in the case of SCG neurons, sigma ligands maximally inhibited peak 
IBa in intrinsic cardiac neurons by ≥95% (data not shown). 
   
Effects of Haloperidol on Ca2+ Channel Inactivation  
Some receptors that modulate Ca2+ channels, such as M4-muscarinic and 
α2-adrenergic receptors have been shown to differentially affect the rapid and 
slow component of Ca2+ channel current decay (Cuevas and Adams 1997; Xu 
and Adams 1993).  To determine whether sigma receptors have a similar effect 
on Ca2+ channel inactivation kinetics, Ca2+ channel currents were evoked by step 
depolarization (2 s) to 0 mV from a holding potential of 90 mV in the absence 
and presence of 10 µM haloperidol.  Figure 7A shows representative responses 
recorded from a single SCG neuron.  Under control conditions, the time-
dependent inactivation of IBa was biphasic, and best fit by the sum of two 
exponential functions with time constants of 198 ms ( 1) and 2.2 s ( 2).  In the 
presence of haloperidol, the inward current was also best fit by the sum of two 
exponential functions, but both 1 and 2 were decreased to 117 ms and 1.1 s, 
respectively.  Following wash out of haloperidol, 1 and 2 returned to near control 
levels and were 171 ms and 1.5 s, respectively.  In five similar experiments, the 
time course of IBa decay was best fit by the sum of two exponential functions with 
mean time constants of 100 ± 15 ms ( 1) and 1.2 ± 0.1 s ( 2).  In all SCG neurons 
studied, haloperidol decreased both 1 and 2 in a statistically significant manner 
(P < 0.01), and mean time constants were 62 ± 11 ms ( 1) and 711 ± 146 ms ( 2; 
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 n = 5).  The peak amplitude of each of the two components of the fit was also 
depressed, with the amplitude of the first component decreasing by 40 ± 11% 
and that of the second component by 35 ± 7%.  In all cells tested, the effect of 
haloperidol on the time course of decay of IBa was reversible on wash out and 
mimicked by ibogaine (data not shown).   
The effect of haloperidol (10 µM) on steady-state inactivation of Ca2+ 
channels in rat SCG neurons was studied using a double pulse protocol.  
Neurons were initially held at 90 mV, and 10-s prepulses from 120 to +10 mV 
were applied in 10-mV increments prior to a voltage step to +20 mV (20 ms) to 
activate (open) the available Ca2+ channels.  A plot of the relative peak current 
amplitude [IBa/IBa(max)] as a function of prepulse voltage is shown in Figure  7B (n 
= 6).  The steady-state inactivation of IBa under control conditions exhibited a 
sigmoidal dependence on voltage and was best fit with a single Boltzmann 
function according to the equation  
IBa = IBa(max)/{1 + exp{(V-Vh)/k]} 
A fit of the mean relative I-V relationship exhibited half-maximal steady-state 
inactivation (Vh) at 27 mV and had a slope parameter (k) of 12.  In the 
presence of haloperidol, however, the voltage dependence of steady-state 
inactivation was best fit by a two-component Boltzmann distribution  
 IBa = i1(IBa(max)/{1 + exp{(Vh1-V)/k1]}) + i2(IBa(max)/{1 + exp{(Vh2-V)/k2]}) 
where i1 and i2 represent the fraction contributed by each component to the final 
function.  The values for i1 and i2 were 0.21 and 0.78, respectively.  The first 
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 component was half-maximally activated (Vh1) at 13 mV and had a slope 
parameter (k1) of 6.3, whereas the second component was half-maximally 
activated (Vh2) at 53 mV and had a slope parameter (k2) of 14.9. 
   
Effects of Haloperidol on the Voltage Dependence of Ca2+ Channel 
Activation  
The voltage dependence of activation was examined by measuring tail 
current amplitude.  Neurons were held at 90 mV, and brief steps (20 ms) to 
various test potentials ( 50 to +100) were applied prior to repolarization to 90 
mV.  Figure 8A shows Ba2+ currents obtained in the absence and presence of 
haloperidol (10 µM) in response to voltage steps to the indicated potentials and 
the ensuing tail currents elicited on repolarization to 90 mV.  The corresponding 
I-V relationship obtained for the peak tail current amplitudes of six neurons is 
shown in Figure 8B.  Haloperidol significantly reduced the peak tail current 
amplitude at all voltages from 10 to +100 mV in a reversible manner.  However, 
at 0mV haloperidol decreased peak IBa tail current amplitude by 57% but by 73% 
at +50 mV.  This effect does not appear to be a use-dependent phenomenon 
since IBa tail current amplitude did not decrease during a train of brief 
depolarizations (5 pulses, 20 ms) to +80 mV or by reversing the voltage protocol 
(data not shown).  Also, at voltages where Ca2+ channels were maximally 
activated, inhibition by haloperidol was comparable (+80 mV, 77%; +90 mV, 78%; 
+100 mV, 76%).  The reason for greater depression of IBa tail current amplitude 
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 by haloperidol at higher depolarizations is a drug-induced shift in Ca2+ channel 
activation.   
Figure 8C shows a plot of the mean peak IBa tail current amplitude 
normalized to maximum IBa tail current amplitude in the absence and presence of 
haloperidol.  Ca2+ channels exhibit sigmoidal activation at potentials positive to 
40 mV under both conditions.  Data points were best fit using a two-component 
Boltzmann distribution (Eq.2).  For control, i1 and i2 were 0.48 and 0.52, 
respectively, whereas in the presence of haloperidol i1 and i2 were 0.70 and 0.20, 
respectively.  Half-maximal activation of the first component (Vh1) shifted from 4 
mV in the absence (control) to 13 mV in the presence of haloperidol, while the 
second component (Vh2) shifted from +38 mV (control) to +22 mV (+haloperidol).  
This sigma receptor-induced shift in the voltage dependence of activation results 
in tail currents of greater amplitude at more negative potentials and is thus 
responsible for the difference in percent inhibition of Ba2+ tail currents by 
haloperidol at low and high depolarizations.  The effects of haloperidol on the 
voltage dependence of Ca2+ channel steady-state inactivation and activation 
were reversible on wash out and were mimicked by ibogaine (data not shown). 
   
Effect of Intracellular Dialysis with GTP and GDP- -S on Sigma Receptor 
Inhibition of IBa  
In some systems, sigma receptors have been shown to couple to effector 
targets via a signal transduction cascade involving a G protein.  To determine 
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 whether a G protein is involved in the sigma receptor-mediated modulation of 
Ca2+ channels in autonomic neurons, intrinsic cardiac neurons were dialyzed with 
pipette solution containing either 100 µM GTP or 100 µM GDP-β-S.  In neurons 
dialyzed with GTP, sigma receptor-induced inhibition of IBa was similar to that 
observed in neurons electrically accessed using the perforated-patch method.  
Figure 9A shows representative currents in response to step depolarizations from 
90 to 0 mV recorded from two neurons dialyzed with either GTP (top traces) or 
GDP-β-S (bottom traces) in the absence and presence of 10 µM haloperidol.  A 
summary of the peak IBa amplitudes elicited on depolarization to 0 mV, 
normalized to their respective control values, under the different experimental 
conditions is presented in Figure  9B.  Haloperidol decreased IBa by 68 ± 8% (n = 
5) in neurons dialyzed with pipette solution containing GTP and by 62 ± 3% (n = 
6) in neurons dialyzed with GDP-β-S.  The difference between these two 
experimental groups was not statistically significant.  DTG inhibition of IBa was 
reversible on wash out of drug when cells were dialyzed with either GTP or GDP-
β-S (data not shown).   
To determine whether the dialysis with GDP-β-S was sufficient to block G 
protein-mediated events, these cells were also exposed to 100 µM ACh to elicit 
muscarinic receptor-evoked inhibition of Ca2+ channels.  Muscarinic receptors 
have been shown to couple to Ca2+ channels via a pertussis toxin-sensitive G 
protein in intrinsic cardiac neurons (Cuevas and Adams 1997).  Following cell 
dialysis with GTP containing pipette solution, ACh depressed IBa by 40 ± 6% (n = 
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3).  This ACh-mediated inhibition was reduced to 17 ± 4 in cells dialyzed with 
GDP-β-S (n = 3), which was significantly different from the reduction observed 
when GTP was used. 
  
 
 
 
Figure 2.1 Detection of sigma-1 receptor transcripts in rat ICG and SCG.  A: 
RNA from rat ICG and SCG were reverse transcribed and amplified via PCR 
using oligonucleotide primers specific for the sigma-1 receptor (sense, 
GTCTTTTGCACGCCTCGCTGTCTGAGTACG; antisense, 
ACCCTCTCTGGATGGAGGTGAGT GC).  B: RT-PCR reaction results for 2 
isolated neurons from rat ICG and SCG using the sigma-1 primers.  A and B: 
arrows indicate predicted size for the sigma-1 receptor product (639 bp), and 
standards are 100 bp ladder.   
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Figure 2.2 Inhibition of Ca2+ channel currents in sympathetic neurons by the 
sigma receptor agonist, haloperidol.  A: family of depolarization-activated Ba2+ 
currents recorded from a single SCG neuron in the absence (Control) and 
presence of 10 µM haloperidol.  B: whole cell current-voltage relation obtained in 
the absence ( ) and presence of 10 µM haloperidol ( ).  Data points represent 
means ± SE for 6 cells. 
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Figure 2.3.  Dose-dependent inhibition of depolarization-activated Ca2+ channels 
by sigma receptor ligands in rat sympathetic neurons.  A: whole cell currents 
evoked from 3 SCG neurons (1-3) by step depolarizations to 0 mV from a holding 
potential of 90 mV in the absence (Control) and presence of haloperidol, (+)-
pentazocine and 1,3-Di-O-tolylguanidin (DTG) at the indicated concentrations.  B: 
peak whole cell IBa amplitude, evoked by depolarizing to 0 mV from 90 mV, 
normalized to control and plotted as a function of sigma ligand concentration.  
Data points represent means ± SE for 5-7 neurons.  The curves represent best fit 
to the data using the Hill equation.  Half-maximal inhibition was 6 µM for 
haloperidol (■), 31 µM for ibogaine (◊), 61 µM for (+)-pentazocine (●), and 133 
µM for DTG (∆), and the Hill coefficient was 1.1 for all compounds.   
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Figure 2.4 Reversibility of DTG-induced block of depolarization-activated Ca2+ 
channels.  A: family of depolarization-activated Ca2+ channel currents recorded 
from a single rat SCG neuron in the absence (Control) and presence of bath-
applied 1 mM DTG (+DTG), and following wash out of drug for the indicated time 
periods.  B: peak Ba2+ current amplitudes before application (○), during 
application (●), and after removal (○) of 1 mM DTG for the cell in A.  Values are 
plotted as a function of time.  Gap represents period during which lower 
concentrations of DTG were applied, with 1 mM DTG application commencing at 
t =13 min.   
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Figure 2.5 Attenuation of DTG-mediated inhibition of Ca2+ channels by the sigma 
receptor antagonist, metaphit.  A: depolarization activated ( 90 to 0 mV) Ba2+ 
currents recorded from 2 SCG neurons in the absence (Control, Metaphit) and 
presence of 100 µM DTG (DTG, Metaphit + DTG).  Bottom traces are from a 
neuron preincubated in metaphit (50 µM) in physiological saline solution (PSS), 
(10 min).  B: bar graph of the relative mean peak IBa (±SE) obtained by step 
depolarizations ( 90 to 0 mV) in control cells (DTG) or cells preincubated in 
metaphit (50 µM, 10 min; Metaphit + DTG) following bath application of 100 µM 
DTG.  Current amplitudes were normalized to their respective controls (absence 
of DTG).  Data were collected from 7 neurons for each condition, and asterisk 
denotes significant difference between the groups (P < 0.01) 
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Figure 2.6 Inhibition of Ca2+ channel currents in rat ICG neurons by sigma 
receptor ligands.  A: Ba2+ currents evoked by step depolarizations to 0 mV from 
90 mV recorded from 4 parasympathetic ICG neurons in the absence (Control) 
and presence of ibogaine, DTG, (+)-pentazocine, and haloperidol at the indicated 
concentrations.  B: peak whole cell Ba2+ current amplitude normalized to control 
recorded in the presence of haloperidol (HAL), ibogaine (IBO), (+)-pentazocine 
(PTZ), and DTG.  Bars represent means ± SE for 3-5 ICG neurons. 
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Figure 2.7 Sigma receptor modulation of time-dependent and steady-state 
inactivation of Ca2+ channels in SCG neurons.  A: Ba2+ currents evoked from a 
single neuron by 2-s depolarizations to 0 mV from a holding potential of 90 mV 
in the absence (Control), presence of 10 µM haloperidol (Haloperidol), and 
following wash out of drug (Wash).  Solid lines represent a best fit of the time 
course of current decay with the sum of 2 exponential functions.  B: relative Ba2+ 
current amplitude as a function of prepulse amplitude in the absence (○) and 
presence (●) of 10 µM haloperidol.  Data points represent means ± SE for 6 
neurons.  Solid lines represent best fit to the data with a single (control) or 2-
component (haloperidol) Boltzmann distribution. 
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Figure 2.8 Sigma receptor evoked shift in voltage dependence of Ca2+ channel 
activation.  A: Ca2+ channel tail currents evoked from a single neuron by 
repolarization to 90 mV from the indicated potentials in the absence (Control) 
and presence of 10 µM haloperidol (Haloperidol).  The time scale is increased 5-
fold at the start of repolarization.  Mean peak tail current amplitude (B) and 
relative peak Ba2+ tail current amplitude (C) evoked by repolarization to 90 mV 
following a brief depolarization to the indicated potentials in the absence (○) and 
presence (●) of 10 µM haloperidol.  Data points represent means ± SE for 6 
neurons.  Solid lines in C represent best fit to the data using a 2-component 
Boltzmann distribution 
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Figure 2.9 Sigma receptor inhibition of Ca2+ channels is not blocked by 
intracellular GDP-β-S.  A: depolarization activate ( 90 to 0 mV) Ba2+ currents 
recorded from neurons dialyzed with pipette solutions containing either 100 µM 
GTP (top traces) or GDP-β-S (bottom traces) in the absence (Control) or 
presence of 10 µM haloperidol (Haloperidol).  B: peak IBa recorded from neurons 
dialyzed with either GTP or GDP-β-S in the presence of 10 µM haloperidol or 100 
µM ACh.  Currents are normalized to their respective controls (absence of drug).  
Asterisk denotes significant difference between groups of cells exposed to ACh. 
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DISCUSSION 
 
The results presented here provide the first evidence of sigma receptors 
being expressed in mammalian parasympathetic and sympathetic neurons.  
Transcripts encoding sigma-1 receptors were detected in individual neurons from 
ICG and superior cervical ganglia in neonatal rats.  Sigma receptors were shown 
to inhibit all Ca2+ channel subtypes present in neurons of both autonomic ganglia 
with high efficacy.  Furthermore, sigma receptors were demonstrated to differ 
from other modulators of Ca2+ in these cells on the basis of their effects on the 
biophysical properties of the channels and the signal transduction cascade 
coupling them to these Ca2+ channels.   
Two pharmacologically distinct subtypes of sigma receptors have been 
identified: sigma-1 and sigma-2 receptors, respectively.  Photoaffinity labeling 
experiments with sigma receptor-specific ligands have also revealed the 
presence of a 25-kDa polypeptide in guinea pig brain corresponding to the sigma-
1 receptor and a polypeptide doublet of 18 and 21 kDa that is believed to 
represent the sigma-2 receptor (Hellewell and Bowen 1990).  The mammalian 
sigma-1 receptor has been cloned in several species including guinea pig, 
human, and rat (Hanner et al., 1996; Kekuda et al., 1996; Seth et al., 1998).  
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These receptors are expressed in the brain and in several peripheral tissues and 
organs (Walker et al., 1990).  Because of the presence of sigma-1 receptors in 
cardiac muscle (Ela et al., 1994), and possibly other tissues associated with ICG 
ganglia or in support cells in the SCG, we used single-cell RT-PCR techniques to 
demonstrate that transcripts for this receptor are present specifically in autonomic 
neurons.  The sequences of the sigma-1 receptor transcripts cloned from both 
ICG and SCG neurons were identical to that reported for the rat brain sigma-1 
receptor (Seth et al., 1998).  No splice variations of the sigma-1 receptor were 
detected in these neurons.  Sequences for two isoforms of the sigma-1 receptor 
have been submitted previously to GenBank (Mei and Pasternak 1998; Wang et 
al., 2000).  One of these isoforms, sigma-1β receptor, was cloned from mouse 
and is reported to have sigma-2-like binding activity (Wang et al., 2000).  
However, transcripts encoding these truncated forms of the sigma-1 receptor 
were not observed, indicating that they do not mediate the cellular responses to 
sigma ligands reported in this study.   
In the present study, the use of sigma receptor agonists suggests that 
sigma receptors inhibit Ca2+ channels in neurons from parasympathetic ICG 
ganglia and sympathetic superior cervical ganglia.  These agonists were shown 
to inhibit Ca2+ channels in over 90% of the cells tested (n>100).  In autonomic 
neurons, various cell membrane receptors have been shown to be coupled to 
Ca2+ channels.  In mammalian ICG neurons, M4 muscarinic, α-adrenergic, 
neuropeptide Y, and µ-opioid receptors have all been shown to depress Ca2+ 
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channel currents (Adams and Trequattrini 1998; Cuevas and Adams 1997; Jeong 
and Wurster 1997a; Kennedy et al., 1998; Xu and Adams 1993).  However, 
maximum inhibition of peak Ca2+ by activation of these receptors is ≤75%, and 
their primary target is N-type calcium channels, which account for ~70% of the 
whole cell calcium current in these cells (Cuevas and Adams 1997; Jeong and 
Wurster 1997a; Xu and Adams 1993).  In contrast, activation of sigma receptors 
in these neurons inhibits ≥95% of the peak current, indicating that all Ca2+ 
channel types are affected.  It has been reported that these cells express N-, L-, 
P/Q-, and R-type calcium channels (Cuevas and Adams 1997; Jeong and 
Wurster 1997b; Xu and Adams 1993).   
The sigma receptor inhibition of heterogeneous populations of Ca2+ may 
have significant physiological implications.  Attenuation of N-type Ca2+ channels 
by ω-conotoxin GVIA fails to block synaptic transmission in parasympathetic 
ganglia, but broad-spectrum Ca2+ channel inhibitors, such as cadmium, eliminate 
excitatory postsynaptic potentials (Seabrook and Adams 1989).  Inhibition of 
multiple classes of Ca2+ channels may contribute to the reported sigma receptor-
mediated decrease in guinea pig ileum longitudinal muscle contraction (Campbell 
et al., 1989; Kinney et al., 1995).  It has been proposed that a decrease in ACh 
release is responsible for this attenuation in muscle contraction (Campbell et al., 
1989) and block of presynaptic Ca2+ would depress transmitter release.  
Therefore activation of sigma receptors may block signaling through autonomic 
ganglia and inhibit modulation of effector targets by peripheral neurons.  In the 
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cardiovascular system, inhibition of parasympathetic input to the heart may 
account  for the increased heart rate, arrhythmias, and sudden cardiac death 
observed in some patients during therapy with haloperidol (Mehta et al., 1979; 
Settle and Ayd 1983; Turbott and Cairns 1984).  Furthermore, haloperidol evokes 
a prolongation of the QT interval in the electrocardiogram (Kriwisky et al., 1990), 
which is similar to that induced by atropine-mediated vagal block (Annila et al., 
1993).   
In addition to affecting a broader population of Ca2+ channel types than 
other endogenous modulators of autonomic Ca2+ channels, activators of sigma 
receptors have profoundly different effects on Ca2+ channel biophysics.  Whereas 
ACh and norepinephrine (NE), for example, have no effects on the steady-state 
inactivation of Ca2+ channels (Cuevas and Adams 1997; Xu and Adams 1993), 
sigma ligands shift the steady-state inactivation curve to more negative 
potentials.  The fact that the voltage dependence of inactivation was best fit by a 
one-component Boltzmann distribution in the absence of sigma receptor 
activation but by a two-component Boltzmann distribution in the presence of 
haloperidol suggests that sigma receptors may not equally modulate steady-state 
inactivation in all Ca2+ channel subtypes.   
Activation of sigma receptors also altered the voltage dependence of 
activation of Ca2+ channels in a manner distinct from other known Ca2+ channel 
inhibitors.  In the presence of sigma receptor agonists, the Ca2+ channel 
activation curve was shifted toward more negative potentials.  Other inhibitors of 
 Ca2+ channels, such as µ-opioid, muscarinic and α-adrenergic agonists shift the 
activation curve to more positive potentials (Adams and Trequattrini 1998; 
Cuevas and Adams 1997; Xu and Adams 1993).  Thus stronger depolarizations 
are required in the presence of these agents to activate the same number of Ca2+ 
channels.  The shift in the Ca2+ channel activation curve toward more positive 
potentials has been explained by a "willing-reluctant" model first proposed by 
Bean (Bean 1989).  According to this model, Ca2+ channels are converted in the 
presence of a modulator from a "willing" state to a "reluctant" state that requires 
stronger depolarization to open the channel.  Such a shift in the voltage 
dependence of activation is not observed here.  Further evidence for the lack in 
willing to reluctant shift in the presence of sigma ligands is provided by 
experiments in which prolonged depolarizations were applied to activate Ca2+ 
channels.  The fast component of the inward Ca2+ current ( 1), represents 
channels in the willing state, and this component was not preferentially inhibited.  
In contrast, ACh and NE primarily depress the fast inactivating component ( 1) in 
long depolarizations and have little effect on the amplitude of 2 (Cuevas and 
Adams 1997; Xu and Adams 1993).  However, ACh also activates "voltage-
independent" mechanisms of Ca2+ channel inhibition that result in depression of 
IBa at all voltages tested (Cuevas and Adams 1997; Mathie et al., 1992), as is 
observed here.  Similarly, NE inhibition of Ca2+ channel activation in rat ICG 
neurons exhibits voltage-dependent and -independent components (Xu and 
Adams 1993).  One of the outcomes of sigma receptor-mediated increase in the 
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 rate of Ca2+ channel inactivation and attenuation of the amplitude of both 1 and 
2 is a greater decrease in net Ca2+ entry through the channels compared with 
other Ca2+ channel inhibitors.   
Previous studies have suggested a possible relationship between sigma 
receptors and calcium channels.  Dextromethorphan, a nonselective sigma 
receptor agonist, decreased K+ depolarization-evoked Ca2+ uptake into brain 
synaptosomes and PC12 cells (Carpenter et al., 1988).  The half-maximal 
inhibition of Ca2+ uptake by dextromethorphan was consistent with the effect 
being mediated by a sigma-2 site, and sigma-2 receptors have been reported in 
brain and PC12 cells (Hellewell and Bowen 1990; Reid et al., 1990).  It has also 
been suggested that some sigma ligands, including dextromethorphan, inhibit 
Ca2+ currents by directly interacting with Ca2+ channels (Church and Fletcher 
1995; Flaim et al., 1985).  Conversely, in frog melanotrophs, micromolar 
concentrations of (+)-pentazocine have been shown to enhance calcium 
conductances through activation of sigma receptors (Soriani et al., 1999).  The 
present study shows that structurally dissimilar sigma ligands are able to 
modulate the biophysical properties of Ca2+ channels.  Since these ligands have 
similar effects on the biophysical properties of the channels, it is unlikely that they 
would be acting on different sites of the channel.  Although the exact binding site 
for these drugs on the cloned sigma-1 receptor has not been identified, any 
single site that permits binding to such a broad array of drugs is likely to be quite 
complex (Walker et al., 1990) and conserved.  Thus the lack of any significant 
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homology between Ca2+ channels and the cloned sigma-1 receptor suggests that 
the effects of sigma ligands are likely mediated by a sigma receptor and not a 
direct effect on the Ca2+ channel.  The argument against a direct effect of sigma 
ligands on Ca2+ channels is significantly strengthened by the observation that  the 
sigma receptor antagonist, metaphit, blocks the DTG-mediated attenuation of 
Ca2+ channels.   
Consistent with the effects of sigma ligands on Ca2+ channels being 
mediated by specific binding of the drugs to a sigma receptor is the finding that 
the rank order potency and IC50 values for the various sigma ligands tested here 
are in agreement with those reported previously for sigma-2 receptors.  Sigma-2 
receptors have been shown to modulate Ca2+ release from intracellular stores in 
human SK-N-SH neuroblastoma cells (Vilner and Bowen 2000).  The rank order 
potency reported in that study, haloperidol > ibogaine > (+)-pentazocine ≈ DTG, 
and micromolar EC50 values are in agreement with our findings.  Sigma-2 
receptors have also been reported to mediate the inhibition of guinea pig ileum 
longitudinal muscle contraction (Kinney et al., 1995).  In that study, haloperidol 
was shown to depress electrically evoked contractions with an IC50 nearly 
identical to that reported here (~6 µM).  In primary cultures of rat frontal cortical 
neurons, sigma-2 receptor activation blocked N-methyl-D-aspartate (NMDA) 
mobilization of intracellular free Ca2+ (Hayashi et al., 1995).  The IC50 for 
haloperidol and (+)-pentazocine inhibition of peak free Ca2+ were ~6 and 40 µM, 
respectively, also in agreement with the values reported here for these drugs.  
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One of the strongest lines of evidence for sigma-2 receptors mediating the 
inhibition of Ca2+ channels in autonomic neurons is our observation that ibogaine, 
a sigma-2-selective agonist (Bowen et al., 1995), exhibits greater potency than 
(+)-pentazocine.  The affinity of sigma-1 receptors for (+)-pentazocine is ~2,000-
fold greater than for ibogaine, whereas the affinity of sigma-2 receptors for 
ibogaine is ~6-fold higher than for (+)-pentazocine (Vilner and Bowen 2000).  The 
IC50 for ibogaine inhibition of IBa in these autonomic neurons is two-fold greater 
than that determined for (+)-pentazocine.   
The primary mechanism by which other known modulators of Ca2+ in 
autonomic neurons depress Ca2+ currents is via the activation of pertussis toxin-
sensitive G proteins (Adams and Trequattrini 1998; Cuevas and Adams 1997; Xu 
and Adams 1993).  However, no such G protein appears to be implicated in the 
signal transduction cascade coupling sigma receptors and Ca2+ channels in these 
cells, since intracellular dialysis with GDP-β-S failed to inhibit the effects of sigma 
ligands.  Furthermore, the inability of cell dialysis to block the effects of sigma 
receptors suggests that a diffusable cytosolic second messenger is likely not 
involved.  Similarly, sigma receptors have been shown to modulate K+ channels 
in rat pituitary cells through a membrane-delimited signaling pathway that does 
not incorporate a G protein (Lupardus et al., 2000).   
Taken together, molecular biology studies and pharmacological studies 
conducted here suggest that both sigma-1 and sigma-2 receptors are expressed 
in ICG and superior cervical ganglion neurons.  However, our experiments 
  54
indicate that only the sigma-2 receptor, which remains to be cloned, couples to 
Ca2+ channels in these cells.  Given that the sigma-2 receptor has been shown to 
be a distinct molecular entity (Hellewell and Bowen 1990), it is doubtful that the 
sigma receptor shown to modulate Ca2+ channels here is a modified form of the 
sigma-1 receptor gene product.  Thus the cellular function of the sigma-1 
receptors found in these autonomic neurons remains to be determined.  
In conclusion, rat ICG and SCG neurons express sigma-1 and sigma-2 
receptors, and activation of these receptors alters the biophysical properties of 
Ca2+ channels and attenuates whole cell Ca2+ channel currents.  
Pharmacological experiments suggest that the modulation of Ca2+ channels is 
mediated by sigma-2 receptors.  Because of the importance of Ca2+ channels in 
the function and regulation of the autonomic nervous system, sigma receptors 
are likely to have a significant role in the modulation of autonomic nerve activity 
and thus on regulation of the cardiovascular system and other effector targets.   
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CHAPTER 3 
SIGMA RECEPTOR ACTIVATION BLOCKS POTASSIUM CHANNELS AND 
DEPRESSES NEUROEXCITABILITY IN RAT ICG NEURONS 
 
INTRODUCTION 
 
 Sigma receptors are non-opioid, non-phencyclidine receptors that are 
distributed throughout the central and peripheral nervous system.  These 
receptors have high affinity for numerous drugs in clinical use including 
psychotherapeutic agents such as antipsychotics (Su,1982) and selective 
serotonin reuptake inhibitors (Narita et al., 1996).  At least two subtypes of sigma 
receptors have been classified based on the findings from biochemical and 
radioligandbinding experiments, and have been designated as sigma-1 and 
sigma-2 (Hellewell and Bowen,1990).  However, to date, only the sigma-1 
receptor has been cloned (Hanner et al., 1996). These receptors have been 
implicated in physiological processes such as learning and memory and in 
pathophysiological disorders such as schizophrenia and depression (Snyder and 
Largent,1989).  More recently, sigma receptors have been linked to the 
development of drug dependence (Ujike et al., 1996).  Sigma receptors also 
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appear to play a role in the regulation of the cardiovascular system, as suggested 
by pharmacological studies using sigma receptor ligands.  For example, it has-
been shown that the sigma receptor ligand, DuP 754, raises the threshold of 
ventricular fibrillation in rats (Lishmanov et al., 1999).  Conversely, the sigma 
receptor agonists, (+) SKF-10,047, 1,3-Di-Otolyguanidin(DTG), and (+)-3-[3-
hydroxyphenyl]-N-(1-propyl)piperidine, have been shown to produce tachycardia 
by activating central and peripheral sigma receptors (Wu and Martin, 1989; 
Lishmanov et al., 2000).  Some of the effects of sigma receptor ligands on the 
cardiovascular system are likely due to activation of sigma receptors on cardiac 
muscle.  Sigma receptors have been detected in cardiac myocytes from neonatal 
and adult rats, and stimulation of these receptors was shown to elicit direct 
inotropic and chronotropic effects on cardiac muscle (Ela et al., 1994; Novakova 
et al., 1995).  However, sigma receptors have also been found in autonomic 
neurons that regulate the cardiovascular system and modulation of the electrical 
activity of these neurons by endogenous or exogenous sigma ligands is likely to 
have profound effects on cardiovascular function.  Mammalian intracardiac 
ganglia (ICG) mediate all parasympathetic input to the heart and serve as the 
common final pathway for autonomic regulation of cardiac function.  Sigma 
receptor ligands, including haloperidol, (+) pentazocine, DTG and ibogaine, were 
shown to inhibit high voltage-activated calcium channels in intrinsic cardiac 
neurons.  The pharmacological profile of the sigma receptor mediating these 
effects was consistent with a sigma-2 receptor (Zhang and Cuevas, 2002).  While 
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sigma-1 receptor transcripts were detected in ICG neurons, no cellular effects 
have been attributed to this receptor.  One possible role for sigma-1 receptors in 
these cells is the modulation of voltage-activated K+ channels.  Recent 
experiments have shown that currents mediated by Kv1.4 and Kv1.5 are 
depressed by the sigma ligand (+)-SKF 10,047 in oocytes injected with Kv 
subunits and the sigma-1 receptor, but not in oocytes injected with the Kv 
subunits alone (Aydar et al., 2002).  Furthermore, sigma-1 receptors were shown 
to alter the kinetic properties of Kv1.4 channels in the absence of ligand, and 
Kv1.4 and Kv1.5 coimmunoprecipitated with the sigma-1 receptor (Aydar et al., 
2002), which led those investigators to propose that the sigma-1 receptor 
functions as a ligand-regulated auxiliary K+ channel subunit. The inhibition of 
delayed outwardly rectifying K+ channels, such as Kv1.5,by verapamil has been 
shown to depress AP firing in intrinsic cardiac neurons, and this phenomenon 
has been implicated in the tachycardia associated with this type IV antiarrhythmic 
drug (Hogg et al., 1999).  However, it remains to be determined if sigma-1 
receptors couple to voltage-activated K+ channels in ICG neurons, and if sigma 
receptor activation can alter the active membrane proprieties of these cells.  By 
regulating the function of K+ channels in parasympathetic ICG neurons, sigma-1 
receptors, and therefore drugs that act on these receptors, may have significant 
influence on the heart.  Experiments were undertaken to determine the effects of 
sigma receptors on currents mediated by voltage-activated K+ channels (IK) and 
the active membrane properties of ICG neurons from neonatal rats. Sigma 
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receptors were shown to decrease the peak amplitude of currents mediated by 
delayed outwardly-rectifying K+ channels (IK(DR)), large conductance Ca2+- 
sensitive K+ channels (IBK), and the M-current (IM).  The rank-order potency of K+ 
channel inhibition by different sigma ligands suggest that the effect is mediated 
by sigma-1 receptors.  Neither cell dialysis nor intracellular application of GDP-ß-
S blocked the effects of sigma-1 receptors on IK, consistent with a direct 
interaction between sigma-1 receptors and the K+channels.  Activation of sigma-
1 receptors also decreased AP firing and changed the AP configuration in ICG 
neurons.  Therefore, sigma-1 receptor activation depresses the excitability of ICG 
neurons and is likely to attenuate parasympathetic input to the heart. 
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METHODS 
 
Preparation of Cell Culture 
The isolation and culture of neurons from neonatal rat ICG ganglia has 
been described previously (Cuevas and Adams, 1994).  Briefly, neonatal rats (2-
7 day old) were euthanized by decapitation and the hearts excised and placed in 
a physiological saline solution containing (mM): 140 NaCl, 3 KCl, 2.5 CaCl2, 0.6 
MgCl2, 7.7 glucose and 10 histidine; pH to 7.2 with NaOH.  Atria were removed 
and incubated for 1 h at 37 oC in physiological saline solution containing 1 mg/ml 
collagenase (Type 2, Worthington).  Following enzymatic treatment, clusters of 
ganglia were dissected from the epicardial ganglion plexus and dispersed by 
trituration in a high glucose culture medium (DMEM), 10% fetal calf serum, 100 
units/ml penicillin and 0.1 mg/ml streptomycin.  The dissociated neurons were 
then plated onto glass cover slips coated with poly-L-lysine, and incubated at 37 
°C under a 95% air-5% CO2 atmosphere for 48-72 hours. 
 
Electrical Recordings 
Electrophysiological recording methods used were similar to those 
previously described (Cuevas et al., 1997).  Active membrane properties and 
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voltage-activated K+ channel currents in ICG neurons were studied under 
current-clamp and voltage-clamp mode, respectively, using the whole cell patch-
clamp technique.  Electrical access was achieved through the use of the 
amphotericin B perforated-patch method to preserve the intracellular integrity and 
prevent the loss of cytoplasmic components and subsequent alteration of the 
functional responses of these neurons (Cuevas and Adams, 1994).  For 
perforated-patch experiments, a stock solution of amphotericin B (60mg/ml) in 
dimethyl sulfoxide (DMSO) was prepared and diluted in pipette solution 
immediately prior to use to yield a final concentration of 198 µg/ml amphotericin 
B in 0.33% DMSO.  Final patch pipette resistance was 1.0-1.3 MΩ to permit 
maximal electrical access under the present recording configuration.  Action 
potentials were elicited by depolarizing current pulses (+100 pA) in absence and 
presence of sigma ligands.  Currents through depolarization-activated K+ 
channels were elicited by step depolarizations from –90 mV to more positive 
potentials (-50 to +70 mV).  For experiments studying the effects of sigma 
receptor activation on IM, cells were held at -30 mV to activate the channel and 
repolarized to -60 mV to deactivate the channels.  Membrane voltages and 
currents were amplified using an Axopatch 200B patch-clamp amplifier (Axon 
Instruments, Union City, CA), filtered at 5 kHz (-3 dB; 4-pole Bessel filter), and 
digitized at 20 kHz (Digidata 1200 B). 
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Data Analysis 
Analyses of these data were conducted using the SigmaPlot 2000 
program (SPSS Science, Chicago, IL).  Data points represent means ± SEM. 
Statistical difference was determined using paired t-test for within-group 
experiments, and unpaired t-test for between groups experiments, and was 
considered significant if p< 0.05. 
Solutions and Reagents 
The bath solution for action potential experiments was a physiological 
saline solution (PSS) containing (in mM) 140 NaCl, 1.2 MgCl2, 3 KCl, 2.5 CaCl2, 
7.7 glucose and 10 HEPES, pH to 7.2 with NaOH.  Potassium channel currents 
were isolated by adding tetrodotoxin (TTX, 400nM) and cadmium chloride 
(CdCl2, 100 µM) to the PSS to inhibit voltage-activated Na+ channel and Ca2+ 
channel currents, respectively.  Pipette solution used for perforated-patch 
experiments contained (in mM): 75 K2SO4, 55 KCl, 5 MgSO4, and 10 HEPES 
(adjust to pH 7.2 with N-methyld-glucamine).  For studies using conventional 
(dialyzing) whole cell recording configuration, the pipette solution contained (in 
mM) 140 KCl, 2 MgCl2, 2 ethylene glycol-bis (ß-aminoethyl ether)- 
N,N,N’,N’-tetraacetic acid (EGTA), 2 Mg2ATP, 0.1 GTP lithium salt (GTP), and 
10 HEPES-KOH, pH to 7.2.  In some experiments GTP was replaced with 100 
µM guanosine 5’-O-(2-thiodiphosphate) trilithium salt (GDP-ß-S) to inhibit G 
protein activation.  All chemical reagents used were of analytical grade. 
Haloperidol; ibogaine hydrochloride; (+)-pentazocine; 1,3-Di-
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Otolylguanidine(DTG); 2S-(2a,6a,11R*]-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-
(2-propenyl)-2,6-methano-3-benzazocin-8-ol hydrochloride ((+)-SKF 10,047); 
tetrodotoxin (TTX);tetraethylammonium chloride (TEA) and linopirdine were 
purchased from Sigma Chemical (St. Louis, MO). 
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RESULTS 
 
Sigma Receptors Activation Inhibit Delayed Outward Rectifying K+ Currents 
Mammalian ICG neurons exhibit currents mediated by delayed outwardly 
rectifying K+ channels (Xi-Moy and Dun, 1995; Hogg et al., 1999) and express 
various subunits that contribute to these channels, including KCNA5 and KCNA6 
(Cuevas, unpublished observation).  Given that sigma-1 receptors have been 
shown to depress heterologously expressed KCNA5 channels (Aydar et al., 
2002), and that inhibition of these channels may have significant effects on the 
function of ICG neurons, it seemed prudent to test the effects of sigma receptor 
activation on currents mediated by voltage-activated K+ channels in these cells.  
Figure 1A shows a family of depolarization-activated K+ currents recorded from a 
single ICG neuron in the absence and presence of DTG (100µM).  Bath 
application of 100 µM DTG depressed peak voltage-activated K+ current 
amplitude at potentials positive to +20 mV.  The voltage-dependence and kinetics 
of the currents observed are consistent with the delayed outwardly rectifying K+ 
current (IK(DR)) previously reported in ICG neurons (Xi-Moy and Dun, 1995).  
Figure 1B shows a plot of the mean peak IK(DR) amplitude in the absence and 
presence of DTG as a function of voltage. The DTG-induced block of IK(DR) was 
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voltage-dependent, with the current being blocked by 26.5 ± 6.2% at +70 mV, but 
only by 1.5 ± 0.1% at +10 mV (n =7).  This difference was statistically significant 
(P < 0.01). 
  
Concentration-Dependent Inhibition of IK(DR) by Sigma Ligands 
Further pharmacological experiments were undertaken to confirm that 
sigma receptors inhibit IK(DR) in ICG neurons and to identify the sigma receptor 
subtype mediating the observed effects.  Figure 2A shows representative 
currents recorded from three ICG neurons in the absence (Control) and presence 
of (+) pentazocine, ibogaine, and DTG, respectively, at the indicated 
concentrations.  All of the sigma ligands tested depressed peak IK(DR) in a 
concentration dependent manner.  A plot of the mean peak IK(DR) as a function of 
drug concentration for several sigma ligands is shown in Figure 2B.  Fits of the 
data using the Hill equation gave half maximal inhibitory concentration (IC50) 
values for haloperidol, (+)-pentazocine, ibogaine , (+)SKF10,047 and DTG of 9.7 
± 0.5, 76.4 ± 7.7 µM, 218.1 ± 7.0 µM, 295.4 ± 45.4 µM and 341.3 ± 
26.0 µM, respectively, and Hill coefficients of ~0.9 for all drugs.  Maximum 
inhibition of IK(DR) by sigma ligands was over 80%.  The IC50 values and rank-
order potency, in particular the observation that (+) pentazocine is significantly 
more potent than ibogaine (p< 0.001) suggests that the effect on IK(DR) is 
mediated by activation of sigma-1 receptors. 
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The Sigma Receptor Antagonist, Metaphit, Depresses the Effect of DTG on 
K+ Channels 
To confirm the fact that the effect of sigma ligands on IK(DR) was mediated 
by activation of sigma receptors and not the result of direct channel block, 
experiments were done using the irreversible sigma receptor antagonist, 
metaphit.  Metaphit rapidly and specifically acetylates sigma receptors, and 
inhibits ligand binding to the receptor (Bluth et al., 1989).  In ICG neurons, 
metaphit has been shown to block sigma-2 receptor mediated attenuation of 
voltage-gated Ca2+ channel currents (Zhang & Cuevas, 2002). Isolated ICG 
neurons were preincubated in 50 µM metaphit (in PSS) for 10 min at room 
temperature.  Following wash out of drug, IK(DR) was activated by depolarizing 
cells to +50 mV from a holding potential of -90mV in the absence and presence 
of 100 µM DTG.  Figure 3A shows representative currents recorded from two 
different ICG neurons without (upper) or with (lower) metaphit preincubation. 
Upon application of DTG, IK(DR) peak amplitude was depressed under both 
conditions, but in cells preincubated in metaphit the response to DTG was 
obtunded.  Figure 3B shows a bar graph of degree of block of IK(DR) by 100 µM 
DTG in control neurons (DTG; n=4) or neurons 
preincubated in metaphit (Metaphit + DTG; n=5).  DTG decreased mean IK(DR) by 
31 ± 3% control cells, whereas in cells exposed to metaphit the decrease was 18 
± 3%.  The difference in DTG attenuation of IK(DR) for the two conditions was 
statistically significant (p<0.05).  Several other sigma receptor antagonists 
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including SM-21, BD-1047 and BD-1067 were tested to determine if these agents 
could block the effects of DTG on IK(DR).  However, all of these drugs themselves 
depressed peak amplitude of IK(DR), suggesting that they are either acting as 
partial agonists of the sigma-1 receptors, as reported previously for BD-1047 
(Zambon et al., 1997), or having direct effects on the K+ channels. 
 
Effect of Intracellular Dialysis with GTP and GDP-ß-S on Sigma Receptor 
Inhibition of IK(DR)
Controversy exists in the literature as to whether sigma receptors couple 
to G proteins and if these second messengers are involved in the regulation of 
ion channels by sigma receptors.  To determine if sigma receptor-mediated 
inhibition of K+ channels in intrinsic cardiac neurons is dependent on G protein 
activation, neurons were dialyzed with pipette solution containing either GTP 
(100 µM) or the G protein inhibitor, GDP-ß-S (100 µM).  Cell dialysis with 100 µM 
GDP-ß-S has previously been shown to successfully block G protein mediated 
signal transduction in intrinsic cardiac neurons (Cuevas and Adams, 1994, 1997;)  
Figure 4A shows representative currents in response to step depolarizations from 
-90 to +50 mV recorded from two neurons dialyzed with either GTP (top traces) 
or GDP-ß-S (bottom traces) in the absence and presence of 100 µM DTG.  The 
inhibition of IK(DR) evoked by this concentration of DTG under dialyzing conditions, 
with GTP in the pipette, was similar to that observed when the intracellular milieu 
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was preserved (~30%).  The DTG induced attenuation of IK(DR) was present when 
the cells were dialyzed with GDP-β-S (Fig 4A, bottom terraces).  A summary of 
the peak IK(DR) amplitudes elicited upon depolarization to +50 mV under the 
different experimental conditions and normalized to their respective control 
values is presented in Figure 4B.  The difference observed between the two 
groups was not statistical significant.  The I-V relationships for 6 neurons 
dialyzed with either GTP or GDP-β-S are shown in Figure 4C and Figure 4D, 
respectively. While dialyzing cells with GDP-β-S decreased the peak IK(DR) 
amplitude, as compared with the cells dialyzed with GTP, DTG attenuated peak 
amplitudes under both conditions to a similar extent. These data suggest that 
neither cell dialysis nor inhibition of G-protein activation blocks sigma-1 receptor-
mediated inhibition of IK(DR).  Thus, neither a diffusible cytosolic second 
messenger nor a G protein couples sigma-1 receptors to IK(DR). 
 
Effects of Sigma Receptor Ligands on AP Firing 
Studies have shown that inhibition of IK(DR) by verapamil in ICG neurons 
can depress AP firing (Hogg et al., 1999).  Experiments were thus conducted to 
determine if sigma receptor modulation IK(DR) has a similar effect on 
neuroexcitability in these cells.  The effects of sigma ligands on the active 
membrane properties of isolated ICG neurons were studied using the 
amphotericin B perforated-patch method under current clamp mode. Figure 5A 
shows a family of APs elicited from a single ICG neuron in response to 
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depolarizing current pulses (100 pA; 300 ms) in the absence (control) and 
presence of 100 µM DTG (DTG), and following washout of drug (wash). DTG 
depolarized the neuron and decreased the number of APs evoked by the current 
injection in a rapidly reversible manner.  In similar experiments, 100 µM DTG 
depolarized neurons from a control value of 50.8 ± 2.1 mV to -49.2 ± 2.4 mV (n 
=9).  DTG also decreased the number of APs evoked by depolarizing membrane 
pulses by 85% (Figre 5B).  Both of these changes were statistically significant 
(p<0.01and p<0.001, respectively).  DTG also altered the AP configuration by 
decreasing both the AP overshoot and afterhyperpolarization, and by slowing 
both the rate of depolarization and rate of repolarization (inset of figure 5A and 
table1).  The effects of DTG were mimicked by haloperidol (10 µM), ibogaine 
(200 µM), and (+) pentazocine (50 µM), which depressed AP firing by 65%, 85% 
and 65%, respectively and changed the configurations of the waveform in a 
reversible manner.  The effects of the sigma ligands on the AP firing and 
configuration are summarized in Table1. 
 
Role of M-Currents in the Effects of Sigma Receptor Activation. 
One possible mechanism by which sigma-1 receptor activation 
depolarizes ICG neurons is via a block of the M-current.  Previous studies have 
shown that inhibition of IM by muscarinic receptor activation depolarizes ICG 
neurons (Cuevas et al., 1997).  The M channels mediating IM are non-inactivating 
and close slowly in response to membrane repolarization from depolarizing 
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holding potentials.  The closing of these channels in ICG neurons upon 
repolarization results in a characteristic inward current relaxation (Cuevas et al., 
1997).  Figure 6A shows whole-cell currents recorded from a single cell in 
response to repolarizing steps to -60 mV from a holding potential of -30 mV in the 
absence (Control) and presence of 1 mM DTG.  The inward relaxation observed 
under control conditions is abolished by application of DTG. Similarly, linopirdine 
(20 µM), a specific blocker of IM (Wallace et al., 2002), eliminates the inward 
relaxation (Figure 6B).  Figures 6C and 6D show bar graphs of mean peak IM 
recorded under control conditions (absence of drug) and when either DTG (n = 4) 
or linopirdine (n = 6) were added, respectively. IM was completely blocked by 
application of either drug, and this effect was reversible after wash out in both 
cases (data not shown). 
 
Effects of Sigma Receptor Activation on BK Currents 
In central and peripheral neurons, AP afterhyperpolarizations (AHP) are 
mediated by the opening of Ca2+-activated K+ channels (IK(Ca)).  Thus far, three 
types of Ca2+- activated K+ channels have been identified on the basis of their 
pharmacology and single channel conductances.  These channels have been 
named according to their unitary conductance: large (big) conductance K(Ca) 
channels (BK), small conductance K(Ca) channels (SK) and intermediate 
conductance (IK). While both BK and SK channels have been found in 
mammalian ICG neurons, neonatal rat ICG neurons only express BK channels 
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(Franciolini et al., 2001; Jelson et al., 2003).  The fact that sigma receptor 
activation decreases the AHP suggests that sigma receptors may modulate 
these channels.  TEA, at micromolar concentrations (200-500 µM), has been 
shown to preferentially block BK channels in ICG neurons and to block the AHP 
more effectively than either charybdotoxin or iberiotoxin (Franciolini et al., 2001).  
Thus, 500 µM TEA was used to distinguish between outward K+ currents 
mediated by BK and other K+ channel types (i.e. IK(DR), IM).  Outward currents 
were evoked by stepping to +50 mV from a -90 mV holding potential in the 
absence and presence of 500 µM TEA.  The net TEA-sensitive current, and thus 
the current mediated by BK channels, was determined by subtracting the current 
remaining after TEA application from that observed under control conditions 
(absence of TEA).  Two distinct TEA-sensitive currents, which differed in their 
time-dependent inactivation kinetics, were seen in our experiments.  These 
currents were expressed in different populations of neurons, with the fast 
inactivating current (BKi) being expressed in 6 of 10 cells and the slowly-
inactivating or noninactivating currents (BKs) being expressed in the remaining 4 
cells. Currents representative of each BK channel subtype are shown in Figures 
7A and 7B. Both the rapidly decaying and the slowly decaying TEA-sensitive 
currents were blocked by 1 mM DTG. Figure 7C and 7D show bar graphs of the 
mean peak and sustained current amplitude obtained from the BKi (n = 6) and 
BKs (n = 4) species, respectively. Both phases of the current were reduced in the 
two current types when 1 mM of DTG was applied. 
  
 
Figure 3.1 Sigma receptor ligands inhibit IK(DR) in rat ICG neurons. A:  
Depolarization activated (-50 to +70 mV; 300 ms) K+ currents recorded from a 
single neuron held at -90 mV in the absence (Control) and presence of 100 µM 
DTG (DTG) or after washout of drug (Wash). B:  Peak IK(DR) current density as a 
function of voltage recorded in a similar manner from 7 neurons in the absence 
(o) and presence (●) of 100 µM DTG.  
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Figure 3.2. Dose-dependent inhibition of IK(DR) by sigma receptor ligands in rat 
ICG neurons.  A: Whole-cell K+ currents evoked from 3 ICG neuron by step 
depolarizations to +50 mV from a holding potential of -90 mV in the absence 
(Control) and presence of (+) pentazocine, ibogaine, and DTG at the indicated 
concentrations. B:  Peak whole-cell IK(DR) current amplitude, evoked by 
depolarizing to +50 mV from -90 mV, normalized to control and plotted as a 
function of sigma ligands concentration.  Data points represent mean ± SEM for 
≥4 observations.  The curves represent best fit to the data using the Hill equation.  
Half-maximal inhibition was 9.7 ± 0.5 µM for haloperidol, 76.4 ± 7.7 µM for (+)-
pentazocine, 218.1 ± 7.0 µM for ibogaine, 295.4 ± 45.4 µM for SKF10,047 and 
341.3 ± 26.0 µM for DTG.  The corresponding Hill coefficients were 1.01 ± 0.05, 
0.69 ± 0.05, 1.14 ± 0.04, 0.84 ± 0.11, 0.97 ± 0.07, respectively. 
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 Figure 3.3 Attenuation of DTG-mediated inhibition of IK(DR) by the sigma receptor 
antagonist, metaphit.  A: depolarization-activated (-90 to 50mV) IK(DR) recorded 
from 2 ICG neurons in the absence (Control) and presence of 100µM DTG 
(DTG).  Bottom traces are from a neuron preincubated in metaphit (50 µM in 
PSS, 10 min).  B: bar graph of the percent inhibition of mean peak IK(DR) (± SE) 
produced by 100 µM DTG in control cells that were not exposed to metaphit 
(DTG) or cells preincubated in metaphit (50 µM, 10 min; Metaphit + DTG).  IK(DR) 
was evoked by step depolarizations (-90 to +50 mV).  Data were collected from 7 
neurons for each condition, and asterisk denotes significant difference between 
the groups (p<0.05) 
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Figure 3.4 Sigma receptor inhibition of IK(DR) is not blocked by intracellular GDP-
ß-S.  A: Depolarization activate (-90 to +50 mV) K+ currents recorded from 
neurons dialyzed with pipette solutions containing either 100 µM GTP or GDP-ß-
S in the absence (Control) or presence of 100 µM of DTG (DTG).  B: Mean (± 
SEM) peak Ik(DR) recorded from neurons dialyzed with either GTP (n=6) or GDP-
ß-S (n=6) in the presence of 100 µM DTG.  Currents are normalized to their 
respective controls (absence of drug). Mean (± SE) peak Ik(DR) current density as 
a function of depolarization voltage (-90 mV, holding potential) recorded from 
neurons dialyzed with pipette solution containing either 100 µM GTP (C, n = 6) or 
100 µM GDP-ß-S (D, n = 6) in the absence (o) and presence (●) of 100 µM DTG. 
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Figure 3.5 Inhibition of AP firing by sigma receptor ligand, DTG, in rat ICG 
neurons.  A: APs fired from an isolated ICG neuron in response to 100 pA 
depolarizing current pulses in the absence (Control) and presence of 50 µM DTG 
(DTG), and following washout of drug (Wash).  Inset is superimposition of first AP 
from Control and DTG traces.  B: Bar graph of the number of APs fired in the 
absence (Control) or presence of 100 µM DTG (DTG) and following washout of 
the drug (Wash).  Asterisk denotes significant difference from Control and DTG 
(p<0.01) (n=7). 
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Figure 3.6 The sigma receptor ligand, DTG, inhibits the M-current in rat ICG 
neurons.  A: Slow inward current relaxation (M-current) induced by repolarizing 
step (-30 mV to -60 mV,250 ms) recorded from a single ICG neuron before 
(Control) and after application of 1mM of DTG (DTG).  B: M-current recorded in 
the absence (Control) and in the presence of 20 µM linopirdine (Linopirdine).  Bar 
graph of mean current amplitudes in the absence (Control) or presence of 1mM 
DTG (C, n = 4) and 20 µM linopirdine (D, n= 6).  The amplitude of the M current 
was defined as the difference between the peak current observed at the start of 
the relaxation (panel A, left trace, black arrow) and the holding current at the end 
of the 250 ms repolarizing step (panel A, left trace, gray arrow).  Asterisks denote 
significant difference from Control (p<0.001). 
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Figure 3.7 Sigma receptor activation blocks large conductance Ca2+-activated K+ 
channel (BK) in rat ICG neurons.  Traces of BK mediated currents recorded from 
two neurons, expressing fast inactivating (A) and slowly-inactivating BK channels 
(B), in the absence (Control) and presence of 1 mM DTG (DTG).  BK mediated 
currents were evoked by step depolarizations to +50 mV from a holding potential 
of –90 mV, and defined as the net TEA sensitive current.  The net TEA-sensitive 
current was determined by subtracting the outward current recorded in the 
presence of 500 µM TEA (with or without DTG) from the outward current 
obtained in the absence of TEA (with or without DTG).  Bar graph of the peak 
and sustained BK current amplitudes recorded in the absence (Control) and 
presence of DTG (DTG, 1mM) in cells expressing fast-inactivating (C, n = 6) or 
slowly-inactivating (D, n = 4) BK channels.  Asterisks denote significant 
difference from control (p<0.05). 
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 RMP (mV) Peak Amplitude 
(mV) 
Rising Slope 
(mV/sec) 
Decay Slope 
(mV/sec) 
After 
Hyperpolarization(mV) 
Control -50.8 ± 2.1 34.4 ± 5.7 55.9 ± 19.9 -30.4 ± 5.9 -21.7 ± 1.3 
DTG (100µM) -49.2 ± 2.4* 4.6 ± 5.6** 11.8 ± 6.3** -8.6 ± 3.6** -12.3 ± 2.1** 
Control -51.0 ± 2.1 25.1 ± 5.2 36.4 ± 8.1 -20.3 ± 2.9 -22.2 ± 2.2 
PTZ (50µM) -48.9 ± 2.3* 11.7 ± 4.9** 12.7 ± 4.0* -7.6 ± 1.7** -16.6 ± 1.6** 
Control -54.5 ± 1.3 35.9 ± 3.5 59.4 ± 6.0 -26.7 ± 2.7 -22.8 ± 1.1 
IBO(200µM) -51.0 ± 2.2* -3.9 ± 6.3** 4.7 ± 1.7** -4.7 ± 1.6** -6.3 ± 2.7** 
 
 
 
Table 3.1 Effects of sigma ligands on the resting membrane potential and AP waveform parameters.  APs were evoked 
by 100 pA current injections.  All drugs were bath applied and the data are shown as: mean ± SE (n=5-6).  Asterisks 
denote significant difference. (*: p<0.05 and **: p<0.01). 
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DISCUSSION 
 
The results presented here show that in neonatal rat ICG neurons 
activation of sigma-1 receptors reversibly inhibited IK(DR), IK(Ca) and IM through a 
pathway that involved neither a diffusible cytosolic second messenger nor a G-
protein.  Furthermore, activation of sigma receptors resulted in the depolarization 
of the neurons and depression of neuroexcitability.  It has been shown that 
sigma-1 receptors are expressed in parasympathetic ICG neurons, but the 
cellular function of these receptors remained unknown.  Whereas sigma-2 
receptors in these cells couple to Ca2+ channels, sigma-1 receptors modulate the 
function of various K+ channels in these neurons.  While the modulation of Ca2+ 
channels in ICG neurons by neurotransmitters is well documented, less is known 
about the regulation of K+ channels in these cells (Adams and Cuevas, 2004).  
Activation of M1 muscarinic receptors in neonatal rat ICG neurons has been 
shown to block IM in these cells (Cuevas et al., 1997), and activation of a PGE2 
receptor inhibits a small-conductance IK(Ca) in adult guinea pig ICG neurons 
(Jelson et al., 2003).  Sigma-1 receptor activation, however, inhibits multiple K+ 
channels subtypes in ICG neurons.  The modulation of K+ channels by sigma 
receptors has been reported in mouse sympathetic neurons, frog melanotrophs, 
and mouse neurohypophysial nerve terminals (Kennedy and Henderson, 1990; 
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Soriani et al., 1998; Soriani et al.,1999a&b; Wilke et al.,1999). The K+ channel 
types that have been shown to be modulated by sigma receptor activation 
include A-Type K+ channels (IA), IK(Ca), IK(DR), and IM, and multiple K+ channels 
types are frequently affected in individual cells (Soriani et al.,1999a, Wilke et 
al.,1999a, Soriani et al.,1999b).  All of those K+ channel subtypes, except A-Type 
K+ channels which are not expressed in ICG neurons, were shown to be affected 
by sigma receptor activation in our study. While sigma receptors have been 
shown to block K+ channels in native cells, the sigma receptor subtype mediating 
these effects has not been definitively identified. The rank order potency for IK 
inhibition by sigma ligands reported here, haloperidol > (+)-pentazocine > 
ibogaine > DTG, suggests that the effect is mediated by sigma-1 receptor 
activation.  In contrast, the rank order potency for sigma ligand inhibition of Ca2+ 
channels in ICG neurons is: haloperidol > ibogaine > (+)-pentazocine > DTG, 
which is consistent with a sigma-2 receptor mediated effect. The IC50 values for 
the various sigma ligands tested here are in agreement with those reported in the 
literature for modulations of voltage-gated K+ channels.  For example, in frog 
pituitary melanotrophs, (+)-pentazocine inhibited delayed outwardly rectifying K+ 
channels with an IC50 of 37 µM , compared to the IC50 of 42 µM reported here.  
Similarly, 100 µM (+)-SKF10047 blocked approximately 50% of the voltage-
activated K+ currents recorded in neurohypophysial nerve terminals (Wilke et al., 
1999a).  Thus, sigma-1 receptors are likely to be responsible for inhibition of K+ 
channels in ICG neurons and in other native cells studied.  The conclusion that 
  85
sigma receptors mediate the inhibition of IK by sigma ligands in ICG neurons is 
strengthened by the observation that metaphit, an irreversible, antagonist of 
sigma receptors, blocks the effects of DTG on IK in these cells.  Considerable 
controversy exists as to the mechanisms by which sigma receptors modulate K+ 
channels.  In frog pituitary melanotrophs, cell dialysis with GTP-β-S and 
preincubation in cholera toxin were shown to inhibit sigma receptor effects on IA 
and IK(DR) (Soriani et al., 1999 a&b), suggesting that sigma receptors couple to 
the K+ channels via a G protein.  G proteins have also been implicated in both 
sigma receptor-mediated activation of phospholipase C and regulation of Ca2+ 
release from intracellular stores (Morin-Surun et al., 1999; Hayashi et al., 2000).  
However, neither cell dialysis nor application of intracellular GTP-β-S blocked the 
inhibition of IK by sigma-1 receptors in ICG neurons.  Thus, sigma receptors 
couple to K+ channels in these cells via a membrane-delimited signal 
transduction cascade that does not involve a G protein.  Our observation is in 
agreement with the direct protein-protein interaction between Sigma-1 receptors 
and K+ channels shown by Jackson and colleagues (Lupardus et al., 2000; Aydar 
et al., 2002).  The net effect of sigma receptor modulation of ion channels in ICG 
neurons at rest is depolarization of the membrane potential.  We have previously 
shown that the IM contributes to the resting membrane potential of ICG neurons 
and that inhibition of this channel depolarizes the cells (Cuevas et al., 1997).  
Given that application of DTG blocks IM, sigma receptor modulation of these 
channels likely accounts for the depolarizations reported here.  Further support 
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for this conclusion comes from the fact that neither inhibition IK(DR) nor IK(Ca) has 
been linked to changes in the resting membrane potential of these neurons 
(Hogg et al., 1999; Xu and Adams, 1992; Jelson et al., 2003).  Inhibition of 
voltage gated Ca2+ channels by sigma-2 receptor activation is also unlikely to 
account for this depolarization since removal of extracellular Ca2+ does not alter 
the resting membrane potential of these cells (DeHaven and Cuevas, 2004).  The 
block of IK by sigma receptors in ICG neuron is associated with decreased AP 
firing, whereas previous studies have shown that sigma receptor block of IK 
enhances neuroexcitability (Soriani et al., 1998).  Our laboratory has shown that 
inhibition of IM is associated with increased excitability of ICG neurons (Cuevas et 
al., 1997), and thus sigma receptor modulation of non-IM K+ channels must be 
responsible for the decreased excitability observed.  The depressed 
neuroexcitability reported here likely results from modulation of IK(DR) by sigma 
receptors.  Verapamil has been shown to convert tonic and adapting ICG 
neurons into phasic neurons via a direct block of IK(DR) (Hogg et al., 1999).  
However, high concentrations of verapamil failed to abolish AP firing in ICG 
neurons, whereas high concentrations of sigma ligands completely blocked the 
genesis of APs in these cells.  The concentrations of (+) pentazocine (50 µM) 
and ibogaine (200 µM) required to appreciably decrease AP firing and alter the 
AP configuration in our study suggest that the effects of sigma ligands on the 
active membrane properties of these cells are primarily mediated by sigma-1 
receptors. However, inhibition of voltage-activated K+ channels alone cannot 
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explain the complete block of AP firing at high concentrations of sigma ligands, 
and thus sigma receptors are likely to affect other channel types that regulate AP 
firing (e.g.voltage-gated sodium channels).  The inhibition of IK(Ca) by sigma 
receptors is also likely to contribute to changes in the active membrane 
properties of ICG neurons.  Two types of sigma receptor-regulated BK currents 
were found in rat ICG neurons, one which exhibited rapid time-dependent 
inactivation, BKi, and a second which showed little or no inactivation, BKs.  The 
presence of distinct subpopulations of BK channels with dissimilar inactivation 
kinetics has been reported in rat adrenal chromaffin cells and mouse neocortical 
pyramidal neurons and (Solaro et al., 1995; Sun et al., 2003).  The inhibition of 
BK currents by sigma receptors would account, at least in part, for the increase in 
AP duration and decrease in AHP reported here, since inhibition of BK by 200 
µM TEA produces similar effects on the APs of these cells (Franciolini et al., 
2001).  While inhibition of voltage-gated Ca2+ channels may contribute to the 
decrease in IK(Ca) amplitude observed in our studies, it is unlikely to exclusively 
account for the block of BK channels observed here.  Evidence for this 
conclusion comes from the fact that concentrations of Cd2+ (100 µM) that inhibit 
all Ca2+ channels in these neurons (Cuevas and Adams, 1997) fail to eliminate 
the AHP in these cells (Franciolini et al., 2001).  Furthermore, in our study, 100 
µM Cd2+ blocked < 5% of IK, whereas 500 µM TEA or Ca2+-free extracellular 
solution blocked ~25% of IK (data not shown).  Taken together, these data 
suggest that sigma-1 receptors are likely having a direct effect on BK channels in 
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ICG neurons.  However, sigma receptor modulation of other mechanisms of Ca2+ 
entry or homeostasis must also be examined to confirm a direct effect on IK(Ca).  
There has been considerable speculation about the role of sigma receptors in the 
cardiovascular system.  While the endogenous ligand responsible for activating 
sigma receptors under physiological and pathophysiological conditions remains 
to be determined, there is data suggesting that some putative sigma receptor 
ligands may affect the heart and coronary vasculature.  For example, 
pregnenolone, a putative sigma ligand (Maurice et al., 2001), increases heart rate 
and cardiac output in anesthetized dogs (Hogskilde et al., 1991).  Such effects 
may in part be due to activation of sigma receptors on ICG neurons.  Similarly, 
various drugs that act on sigma receptors, such as haloperidol, have significant 
effects on the heart (Monassier and Bousquet, 2002).  Our observations raise the 
possibility that the cardiovascular effects of these compounds may be mediated 
by their modulation of the electrical activity of intrinsic cardiac neurons.  In 
conclusion, stimulation of sigma-1 receptors inhibits multiple voltage-gated K+ 
channel subtypes and depresses excitability in ICG neurons.  Thus, activation of 
sigma-1 receptors in these cells is likely to attenuate parasympathetic input to the 
heart and, consequently, affect cardiovascular function. 
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CHAPTER 4 
SIGMA RECEPTORS ACTIVATION INHIBIT VOLTAGE-GATED SODIUM 
CHANNELS IN RAT ICG NEURONS 
 
INTRODUCTION 
 
 Sigma receptors have been shown to modulate a variety of cell membrane 
ion channels, including voltage-gated K+ ( Kennedy and Henderson, 1990; 
Soriani et al., 1998; Wilke et al., 1999; Zhang and Cuevas, 2005) and Ca2+ 
channels (Soriani et al., 1999b; Zhang and Cuevas, 2002).  The effects of sigma 
receptors on voltage-gated Na+ channels, which play very important role in 
cellular functions of central and peripheral neurons, as well as muscle cells, have 
never been studied.  We have shown that sigma receptors activation not only 
inhibits the action potential (AP) firing but also decreases the amplitude of AP 
overshoot (Zhang and Cuevas, 2005).  Inhibition of K+ currents alone cannot 
explain these effects, which suggests other channels are involved and Na+ 
channels could be one of them. 
. Voltage-gated Na+ channels are responsible for the initiation and 
propagation of APs in both nerve and muscle cells (Hille 2001).  Modulation of 
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Na+ channels will influence the threshold of AP generation, as well as the 
frequency of AP firing.  So voltage-gated Na+ channels are primary targets for the 
antiepileptic drugs and are used for identification and development of new 
anticonvulsants (Ragsdale and Avoli, 1998; Chao and Alzheimer, 1995; Taylor 
and Narasimhan, 1997).  In addition to the antiepileptic action of voltage-gated 
Na+ channels blockers, some other Na+ channel blockers are also used in the 
treatments of neuropathic pain (Deffois et al., 1996), arrhythmia (Catterall 1981), 
head trauma and stroke (Baumgold and Spector 1987; Meldrum 1994; Taylor 
and Narasimhan 1997). 
 Voltage-gated Na+ channels also play important roles in cardiac functions 
and the modulators of voltage-gated Na+ channels have been shown enormous 
potential for therapeutic advances in the treatment of heart failure (Doggrell et al., 
1994; Doggrell and Liang, 1998).  Mammalian intracardiac ganglia (ICG) are 
thought to exert local regulation over cardiac function by integrating information 
from efferent and afferent pathways of both parasympathetic and sympathetic 
origin (Moravec and Moravec, 1987) and the ICG neurons express similar types 
of Na+ channels as CNS.  So investigating the effects of sigma receptors on 
voltage-gated Na+ channels in ICG neurons will help understanding the cellular 
effects of these receptors, as well as providing more information on the 
mechanisms of the effects of these receptors, especially in the cardiovascular 
system.  
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 Experiments were undertaken to determine the effects of sigma receptors 
on voltage-gated Na+ channels and the AP firing latency of ICG neurons from 
neonatal rats.  The sigma ligands used here include: DTG, ibogaine, (+) 
pentazocine and BD1047.  These compounds have been selected because they 
are structurally dissimilar, which will help to rule out other nonspecific effects, for 
example, direct binding to Na+ channels or through other receptors.  Also these 
compounds have different selectivies for two subtypes of sigma receptors, which 
will help to differentiate the receptor subtype that mediates the modulations of 
Na+ channels.  Sigma receptor ligands were shown to have inhibitory effects on 
the current mediated by voltage-gated Na+ channels (INa) and shifted the steady-
state inactivation of Na+ channels to more negative potentials.  Activation of 
sigma receptors also increased the latency of AP generation produced by 
depolarizing current ramps. 
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METHODS 
 
Preparation of Cell Culture 
 The isolation and culture of neurons from neonatal rat ICG ganglia has 
been described previously (Cuevas and Adams, 1994).  Dissociated neurons 
were plated onto poly-L-lysine coated glass coverslips and incubated at 37°C for 
36-72 hr under a 95% air, 5% CO2 environment prior to the experiments. 
 
Electrical Recordings 
Electrophysiological recording methods used were similar to those 
previously described (Cuevas et al., 1997).  Voltage-activated Na+ channel 
currents in ICG neurons were studied by using the whole cell patch-clamp 
technique under voltage-clamp mode.  The conventional (dialyzing) whole cell 
recording technique was used in the experiments studying current-voltage 
relationship, while the amphotericin B perforated-patch method was used in other 
experiments.  For perforated-patch experiments, a stock solution of amphotericin 
B (60mg/ml) in dimethyl sulfoxide (DMSO) was prepared and diluted in pipette 
solution immediately prior to use to yield a final concentration of 198 µg/ml 
amphotericin B in 0.33% DMSO.  Final patch pipette resistance was 1.0-1.3 MΩ 
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to permit maximal electrical access under the present recording configuration.  
Currents through depolarization-activated Na+ channels were elicited by step 
depolarizations from –90 mV to more positive potentials (-50 to +100 mV).  For 
experiments studying the effects of sigma receptor on steady state inactivation of 
Na+ channel, cells were prepulsed to different voltage (-120 mV to 0 mV) from 
holding potential of -90 mV and then depolarized to 0 mV to activate the channel.  
AP was evoked by current ramp (0 to 200 nA, 400 ms) and the latency of AP 
generation was determined as the time interval from onset of the current ramp to 
the point at which the rising phase of the AP crossed 0 mV.  Membrane voltages 
and currents were amplified using an Axopatch 200B patch-clamp amplifier 
(Axon Instruments, Union City, CA), filtered at 5 kHz (-3 dB; 4-pole Bessel filter), 
and digitized at 20 kHz (Digidata 1200 B). 
 
Solutions and Reagents 
The bath solution used in Na+ channel experiments was a physiological saline 
solution (PSS) composed of (in mM):70 NaCl, 70 tetraethylammonium chloride 
(TEA), 5 BaCl2, 1.2 MgCl2, 7.7 glucose, 0.1 cadmium chloride (CdCl2), and 10 
HEPES (pH to 7.2 with NaOH).  Barium and TEA were used to block voltage-
gated K+ channels and cadmium was used to block voltage-gated Ca2+ channels.  
Pipette solution used for Na+ channel experiments contained (in mM): 130 CsCl, 
10 NaCl, and 10 HEPES (adjust to pH 7.2 with CsOH).  The bath solution for AP 
experiments was a physiological saline solution (PSS) containing (in mM) 140 
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NaCl, 1.2 MgCl2, 3 KCl, 2.5 CaCl2, 7.7 glucose and 10 HEPES, pH to 7.2 with 
NaOH.  Pipette solution used for AP experiments contained (in mM): 75 K2SO4, 
55 KCl, 5 MgSO4, and 10 HEPES (adjust to pH 7.2 with N-methyld-glucamine).  
All chemical reagents used were of analytical grade. Ibogaine hydrochloride; (+)-
pentazocine; 1,3-Di-Otolylguanidine(DTG); BD1047, and tetraethylammonium 
chloride (TEA) were purchased from Sigma Chemical (St. Louis, MO). 
 
Data Analysis 
Analyses of these data were conducted using the SigmaPlot 2000 
program (SPSS Science, Chicago, IL).  Data points represent means ± SEM. 
Statistical difference was determined using paired t-test, and was considered 
significant if p< 0.05. 
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RESULTS 
 
Sigma Receptor Activation Inhibits Voltage-Gated Na+ Channel Currents. 
 Sigma receptors have been shown to inhibit AP firing and decrease AP 
overshot.  One of the mechanisms by which sigma receptors may modulate AP 
firing is through inhibition of voltage-gated Na+ channels.  Voltage-gated Na+ 
channel currents were isolated by inhibiting Ca2+ currents with extracellular Cd2+, 
and K+ currents with extracellular TEA and intracellular Cs+.  Figure 1A shows a 
family of depolarization-activated Na+ currents recorded from a single ICG 
neuron in the absence and presence of 100 µM ibogaine.  Under control 
conditions, INa was activated at approximately -30mV and the I-V relation was 
maximal at -10 mV, reversing at approximately +70 mV.  The voltage 
dependence and kinetics of the currents observed are consistent with voltage-
gated Na+ channel currents characterized in ICG neurons (Xu and Adams, 1992).  
Bath application of 100 µM of ibogaine depressed the peak INa at potentials 
positive to -20 mV and shifted the reversing potential from +70 mV to +50 mV.  
Sigma-1 receptor agonist, pentazocine, at 100 µM concentration, had similar 
effects (data not shown). 
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Concentration-dependent Inhibition of INa by Sigma Ligands 
 Further pharmacological experiments were undertaken to confirm that 
sigma receptor activation mediated the inhibitory effects of INa of sigma ligands 
and to identify the sigma receptor subtype mediating the observed effects.  
Figure 2A shows representative currents recorded from single ICG neuron in the 
absence (control) and presence of (+)-pentazocine (PTZ), at the indicated 
concentration.  A plot of the mean peak INa as a function of drug concentration for 
several sigma ligands is shown in Figure 2B.  All of the sigma ligands tested 
depressed peak INa in a concentration-dependent manner.  Fits of the data using 
the Hill equation gave half-maximal inhibitory concentration (IC50) values for 
DTG, ibogaine and pentazocine of 30.0 µM, 30.9 µM and 50.8 µM, respectively, 
and Hill coefficients of ~1.0 for all drugs.  Maximal inhibition of INa was more than 
90%. 
 BD 1047 was claimed as sigma-1 receptor antagonist (Matsumoto et al., 
1995 ), however, it was also reported as partial agonist of sigma receptors 
(Zambon et al., 1997).  In our system, we have shown that BD1047 had similar 
effects as sigma receptors agonist as to block K+ channel currents (data not 
shown).  Effects of BD1047 on voltage-gated Na+ channels are shown in Figure 
3.  Figure 3A shows representative currents recorded from single neuron in the 
absence and presence of different concentrations of BD1047, as indicated.  
Similar as sigma receptor agonists, BD1047 dose-dependently depressed INa and 
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the IC50 value for BD1047 was 54.8 µM, which suggests it is either a partial 
agonist of the sigma receptors or has direct effects on the Na+ channels. 
 The effect of sigma ligands on INa amplitude was reversible on wash out. 
Figure 4A shows a family of Na+ currents evoked by step depolarization from a 
single neuron in the absence (control), presence (+DTG), and following wash out 
of the sigma ligand, DTG (wash).  Following inhibition of INa, the current 
recovered gradually and similar reversal of inhibition was observed for all sigma 
ligands tested here (data not shown).  
 
Effects of Sigma Receptors Activation on Voltage-gated Na+ Channel 
Inactivation 
 The effects of DTG (30 µM) on steady-state inactivation of Na+ channels in 
rat ICG neurons was studied using a double pulse protocol.  Neurons were 
initially held at -90 mV, and 50 ms prepulses from -120 to 0 mV were applied in 
10 mV increments prior to a voltage step to 0mV (50 ms) to activate the available 
Na+ channels.  A plot of the relative peak current amplitude (I/Imax) as a function 
of prepulse voltage is shown in Figure 5.  The steady-state inactivation of INa 
exhibited a sigmoidal dependence on voltage and was best fit with a single 
Boltzmann function according to the equation 
INa = INa(max)/{1 + exp{(V-Vh)/k]} 
In the absence of DTG, a fit of the mean relative I-V relationship exhibited half-
maximal steady-state inactivation (Vh) at -50 mV and had a slope parameter (k) 
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of 7.5.  While in the presence of DTG, a fit of mean relative I-V relationship 
exhibited Vh at -64 mV and k of 15. 
 
Effects of Sigma Receptors on the Latency of AP Generation 
 One of the important functions of voltage-gated Na+ channel is the 
initiation and propagation of AP.  Effects of sigma ligands on the latency of AP 
generation were tested during a 400 ms depolarizing current ramp by using the 
perforated patch whole cell recording configuration under current clamp mode.  
Figure 6A shows a family of AP in response to depolarizing current ramp in the 
absence and presence of 30 µM of DTG.  The latency of AP determined as the 
time interval from onset of the current ramp to the point at which the rising phase 
of the AP crossed 0 mV (Parson et al., 2002) was significantly increased by DTG 
(~35%).  DTG also decreased the AP firing, as well as altered AP configuration 
as reported before (Zhang and Cuevas, 2005).  The effects of DTG were 
mimicked by 50 µM of ibogaine, (+)-pentazocine and BD1047, which increased 
the latency of AP firing by 15%, 20% and 15% respectively and the effects of all 
sigma ligands are reversible after wash out of the drug (data not shown). 
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Figure 4.1 Inhibition of Na+ channel currents in rat ICG neurons by the sigma 
receptor agonist, DTG.  A: Whole-cell, Na+ currents evoked by depolarizing test 
pulses (-50 to +100 mV) from a holding potential of -90 mV in the absence 
(Control) or presence of 100 µM ibogaine (Ibogaine).  B:  Whole cell current-
voltage relation obtained in the absence and presence of 100 µM DTG.  C:  
Whole cell current-voltage relation obtained in the absence and presence of 100 
µM ibogaine.  Data points represent means ± SE for 3-4 cells..   
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Figure 4.2 Dose-dependant inhibitions of depolarization-activated Na+ channel 
currents by sigma receptors agonists in rat ICG neurons.  A:  Whole cell Na+ 
currents evoked from a ICG neuron by step depolarizations to -10 mV from a 
holding potential of -90 mV in the absence (Control) and presence of (+)-
pentazocine (PTZ) at the indicated concentration.  B: Peak whole cell INa 
amplitude, evoked by depolarizing to -10 mV from -90 mV, normalized to control 
and plotted as a function of sigma receptors agonists, (+)-pentazocine (PTZ), 
ibogaine (IBO) and DTG, concentrations. Data points represent mean ± SE for 4-
5 neurons.  The curves represent best fit to the data using the Hill equation.  
Half-maximal inhibition was 50.8 µM for (+)-pentazocine, 30.9 µM for ibogaine 
and 30.0 µM for DTG and the hill coefficient was 1.0 for all compounds. 
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Figure 4.3 Dose-dependant inhibitions of depolarization-activated Na+ channel 
currents by sigma receptors antagonist or partial agonist, BD1047 in rat ICG 
neurons.  A:  Whole cell Na+ currents evoked from a ICG neuron by step 
depolarizations to -10 mV from a holding potential of -90 mV in the absence 
(Control) and presence of BD1047(BD1047) at the indicated concentration.  B: 
Peak whole cell INa amplitude, evoked by depolarizing to -10 mV from -90 mV, 
normalized to control and plotted as a function of concentration of BD1047.  Data 
points represent mean ± SE for 4 neurons.  The curves represent best fit to the 
data using the Hill equation.  Half-maximal inhibition was 54.8 µM and the hill 
coefficient was 1.0. 
 . 
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Figure 4.4 Reversibility of DTG-induced block of voltage-gated Na+ channels.  A: 
Family of depolarization-activated Na+ channel currents recorded from a single 
ICG neurons in the absence (Control) and presence of bath-applied 300 µM DTG 
(+DTG), and following wash out of drug (Wash).  B: Peak Na+ channel current 
amplitude before and during application of 300 µM DTG and after removal of 
DTG for the cell in A. Values are plotted as a function of time. Gap represents 
period during which lower concentrations of DTG were applied, with 300 µM DTG 
application commencing at t=20 min. 
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Figure 4.5 Sigma receptor modulation of steady-state inactivation of Na+ 
channels in rat ICG neurons.  Relative Na+ current amplitude as a function of 
prepulse amplitude in the absence (control) and presence of 30 µM DTG (DTG). 
Data points represent means ± SE for 7 neurons. Solid lines represent best fit to 
the data with a single component Boltzmann distribution. 
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Figure 4.6 Sigma receptors ligands increased the latency of AP generation in rat 
ICG neurons.  A: Example recording of AP generated by a 400 ms depolarizing 
current ramp from one neuron prior to (solid line) and during DTG (30 µM) (dash 
line) treatment.  B: Bar graphs summarized the AP latency for multiple neurons 
before (Control) and after application of sigma receptors ligands as indicated.  
The concentrations for sigma ligands are: 30 µM of DTG, and 50 µM for 
pentazocine (PTZ), ibogaine (IBO) and BD 1047.  Asterisks indicated a 
significant difference between conditions using a paired t-test. (*: p<0.05, **: 
p<0.01) 
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DISCUSSION 
 
 The results presented in this chapter provide the first evidence of 
modulation of voltage-gated Na+ channels by sigma receptor ligands.  Sigma 
ligands dose-dependently inhibited INa in a reversible manner and shifted the 
steady-state inactivation to more negative potentials.  Furthermore, activation of 
sigma receptors increased the latency of AP generation. 
 It has been shown in ICG neurons that sigma receptor ligands inhibit 
voltage-gated K+ and Ca2+ channels through sigma-1 and sigma-2 receptor 
activation, respectively.  Previous experiments also showed that sigma receptor 
ligands, at high concentration, abolish AP firing in these neurons.  Although the 
inhibition of K+ and Ca2+ channel currents contribute to the effects on AP firing, it 
can not explain the significant decrease in the amplitude of the first AP overshoot 
and complete block of AP firing at higher concentrations.  Another possible target 
of modulation by sigma receptors is voltage-gated Na+ channels, which are 
responsible for the generation and conduction of AP in neurons.  Like rat 
sympathetic neurons, voltage-gated Na+ channels in rat intracardic neurons are 
TTX sensitive, with complete blockade at 300 nM TTX (Xu and Adams, 1992).  
The data presented here show that sigma ligands inhibit the voltage-gated Na+ 
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channels in a voltage-dependent manner.  A shift in the reversal potential of Na+ 
channel to less positive potentials was also observed.  One reason for this shift is 
incomplete blockade of outward K+ currents by TEA (extracellular) and Cs2+ 
(intracellular).  Compared with Na+ channel inhibition, both DTG and ibogaine 
have less potency for blocking K+ channels and at 100 µm of concentration, they 
only block about 20% of total outward K+ currents (Zhang and Cuevas, 2005).  
So the outward current seen at +70 mV in the presence of DTG and ibogaine is 
an artifact due to K+ current contamination.  In contrast, pentazocine, which has 
similar potency of blocking Na+ and K+ channels, does not shift the reversal 
potential of Na+ channels (data not shown).  The similar IC50 values of blocking 
Na+ and Ca2+ channels of selective sigma-1 and sigma-2 receptor ligands, (+) 
pentazocine (51 µM compared with 61 µM) and ibogaine (31 µM compared with 
31 µM) suggest that like blocking of voltage-gated Ca2+ channels, sigma ligands 
inhibit the voltage-gated Na+ channels also through sigma-2 receptor activation.  
However this cannot explain the high potency of DTG which has equal affinity for 
sigma-1 and sigma-2 receptors of blocking Na+ channels (IC50= 30 µM), 
compared with Ca2+ (133 µM) and K+ channels (341 µM) inhibition.  One 
possibility is that DTG has direct effect on voltage-gated Na+ channels. This is 
consistent with our observations that the inhibitory effect of DTG on Na+ channels 
is not inhibited by the sigma receptor antagonist, metaphit (data not shown) 
which blocked the inhibitory effects of DTG on voltage-gated Ca2+ and K+ 
channels (Zhang and Cuevas, 2002; Zhang and Cuevas, 2005). 
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 Voltage-gated Na+ channels are known to undergo two distinct inactivation 
processes, a fast and a slow inactivation process, which occur within a few 
milliseconds and a few seconds, respectively.  In ICG neurons, the fast 
inactivation process, which is mainly involved in the current shape and the 
INamax (Ruff et al., 1996), was determined by double-pulse protocol in our 
experiments.  Our results show that DTG shift the steady-state inactivation to 
more negative potentials.  This effect is also seen as other sigma ligands (data 
not shown).  Thus the shifting of the steady-state inactivation of Na+ channels to 
more negative potentials attribute at least in part to the inhibition of INa by sigma 
receptors activation.   
 AP generation is determined by complex interaction of the voltage- and 
time-dependent properties of primarily Na+ and K+ selective ion channels (Hille, 
2001).  In different types of neurons, the contribution of the generation of AP 
firing by different ion channels is different.  For example, in guinea-pig 
sympathetic neurons (Locknar et al., 2004) and mudpuppy parasympathetic 
neurons (Parsons et al., 2002; Barstow et al., 2004), the outward current which is 
activated by Ca2+ -induced calcium release (CICR) at membrane voltages 
approaching the threshold for AP initiation regulates AP generation, and the 
disruption of CICR by thapsigargin, ryanodine and Cd2+ decreased the latency of 
AP generation in these neurons.  Parson et al proposed the mechanism of this 
effect that when membrane depolarization approach the threshold for AP 
generation, Ca2+ influx through voltage-dependent Ca2+ channels initiates CICR.  
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The Ca2+ released from internal stores raises the intracellular Ca2+ 
concentrations in domains between the ER and the plasma membrane to levels 
high enough (≥40 µM) to activate membrane outward currents that decrease the 
effectiveness of the depolarizing current (Parsons et al., 2002).  Also in these 
neurons, big Ca2+- activated K+ channels (BK), which are at least in part 
activated by CICR, regulate the generation of AP as well, and blocking the BK by 
iberiotoxin or 500 µM of TEA decrease the latency of AP generation (Parsons et 
al., 2002; Locknar et al., 2004).  The common property of these two types of 
neurons is that none of them express M-currents or express M-currents in only a 
small subpopulation of cells.  While in mammalian intracardiac neurons that 
express M-current, CICR inhibition did not affect the latency of AP generation 
(K.L. Barstow & R.L. Parson, unpublished observations; Dehaven and Cuevas, 
2004).  Therefore in rat ICG neurons, the initiation of AP firing is determined by 
voltage-dependent Na+ channels and M-channels.  Since blocking M-current, 
which opposes depolarizing stimuli, would decrease the latency of AP firing, the 
increased latency of AP firing by sigma receptors ligands must be through the 
inhibition of voltage-gated Na+ channels.  At normal resting membrane potential, 
in the presence of sigma ligands, a smaller portion of Na+ channels is available 
for activation by excitatory depolarization. 
 Sigma receptor ligands have been shown to exert neuroprotective effects 
both in vivo and in vitro (Lobner and Lipton 1990; Poignet et al., 1992; Takahashi 
et al., 1996; Lockhart et al., 1995; Kimura et al., 1998 Goyagi et al., 2001;). but 
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the mechanisms of this effect are not well known.  Disturbance in intracellular ion 
homeostasis induced by ischemia is implicated in the initiation and progression of 
neuronal injury.  It has been proposed that the mechanism of neuronal toxicity 
during oxygen/glucose deprivation is the increase of glutamate efflux into the 
intracellular space by overactivating glutamate receptors, calcium channels and 
sodium channels (Kimura et al., 1998).  The neuroprotective effects of the Na+ 
channel blocker TTX have been demonstrated both in vivo and in vitro (Prenen et 
al., 1998; Boening et al., 1989; Yamasaki et al., 1991; Weber and Taylor, 1994; 
Xie et al., 1994).  Even though there is no clear evidence shown that sigma 
receptors modulate voltage-gated Na+ channels in central nervous system, in rat 
hippocampus, sigma ligands have been shown to suppress CA1 neuronal activity 
by increasing the threshold of action potential firing (Ishihara and Sasa, 2002).  
Inhibition of voltage-gated Na+ channels may mediate this effect and these 
effects on the hippocampal neurons may contribute to the neuroprotective effects 
of sigma ligands. 
 The present data indicate that sigma ligands have inhibitory effects on 
voltage-gated Na+ channels and this effect causes the threshold of AP 
generation to increase, as well as the amplitude of AP overshoot to decrease.  In 
parasympathetic neurons, the inhibition of the AP firing in response to 
depolarizing stimuli may be expected to reduce the bradycardia associated with 
vagal nerve stimulation in vivo, leading to tachycardia.  One of the common side 
effects of local anesthetics, such as ketamine, is increasing the heart rate.  It has 
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been shown that ketamine inhibits Na+ but not K+ channels in brainstem 
parasympathetic cardiac neurons and this action may mediate the decrease in 
parasympathetic cardiac activity and increase the heart rate as seen in surgical 
patients (Irnaten et al., 2002).  Thus, our data suggest that the tachycardia effect 
caused by sigma ligands (+)-SKF-10,047, DTG and (+)-3-[3-hydroxyphenyl]-N-
(1- propyl)piperidine (Wu and Martin, 1989; Lishmanov et al., 2000b) may be 
mediated in part by the inhibition of voltage-gated Na+ channels in rat ICG 
neurons via the activation of sigma receptors.  Further, these results on 
peripheral neurons have broad implications in CNS and stroke.  
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CHAPTER 5 
SUMMARY 
 
The effects of sigma receptors activation on voltage-gated ion channels, 
including Ca2+, K+ and Na+ channel, were investigated in neonatal rat autonomic 
neurons.  The results presented here provide the first evidence that sigma-1 
receptor transcripts are expressed in superior cervical ganglia (SCG) and 
intracardiac ganglia (ICG) neurons, which mediate sympathetic and 
parasympathetic input to the heart, respectively. Furthermore, activation of 
sigma-1 or sigma-2 receptors modulates voltage-gated ion channels and 
decreases the excitability of these cells. 
 The sigma-1 receptor has been cloned in several species and these 
receptors are expressed in brain and various peripheral tissues and organs 
(Walker et al., 1990).  By using single cell RT-PCR techniques, we found that 
sigma-1 receptor transcripts are present specifically in both SCG and ICG 
neurons, with only the conventional isoform expressed in these cells. 
 The effects of sigma ligands, (+)-pentazocine (selective sigma-1 receptor 
agonist), ibogaine (selective sigma-2 receptor agonist), DTG (sigma receptor 
agonist with equal affinity of sigma-1 and sigma-2) and haloperidol (sigma-2 
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receptor agonist), on voltage-gated Ca2+ channel currents were studied by using 
whole cell patch-clamp technique under voltage-clamp mode in SCG and ICG 
neurons.  Our data showed that sigma receptor agonists inhibit Ca2+ channel 
currents in a dose-dependent manner and reversibly, with maximal inhibition of 
over 95% of the peak current amplitude, indicating that all Ca2+ channel types 
which include N-, L-, P/Q, and R-type Ca2+ channels are affected.  In addition to 
affecting a broad population of Ca2+ channel types, sigma ligands have 
significant effects on the kinetic properties of Ca2+ channels.  In the presence of 
sigma ligands, the steady-state inactivation of Ca2+ channels shifted to more 
negative potentials.  In control cells, the inactivation curve was best fit by a one-
component Boltzmann distribution, but by a two-component Blotzmann 
distribution in the presence of sigma ligands. This observation suggests that 
sigma receptors may not equally modulate steady-state inactivation in all Ca2+ 
channel subtypes found in these cells.  Sigma receptors activation also altered 
the voltage-dependence of activation of Ca2+ in a manner distinct from other 
known Ca2+ channel inhibitors.  In the presence of sigma receptor ligands, the 
Ca2+ activation curve was shifted toward more negative potentials.  In contrast, 
other inhibitors of Ca2+ channels, such as muscarinic and α-adrenergic agonists, 
shift the activation curve to more positive potentials (Cuevas and Admas 1997; 
Xu and Admas 1993).  Thus, stronger depolarizations are required in the 
presence of these agents to activate the same number of Ca2+ channels.  The 
structure dissimilarity of sigma ligands and the lack of any significant homology 
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between Ca2+ channels and the cloned sigma-1 receptor suggest that the effects 
of sigma ligands are likely mediated by a sigma receptor and not a direct effect 
on the Ca2+ channel.  This is also approved by the observation that the sigma 
receptor antagonist, metaphit that specifically acetylate sigma receptors and 
block ligand binding (Bluth et al., 1989), blocked the DTG-mediated attenuation 
of Ca2+ channels.  The half-maximal inhibitory concentration (IC50) for 
haloperidol, ibogaine, (+)-pentazocine and DTG were 6, 31, 61 and 133 µM, 
respectively.  The rank order potency of haloperidol > ibogaine > (+)-pentazocine 
> DTG is consistent with the effects on Ca2+ channels being mediated by a 
sigma-2 receptor.  The primary mechanism by which other known modulators of 
Ca2+ in autonomic neurons depress Ca2+ current is via the activation of pertussis 
toxin-sensitive G protein (Cuevas and Adams, 1997).  However, no such G-
protein appears to be implicated in the signal transduction cascade coupling 
sigma receptors and Ca2+ channels in these cells, since intracellular dialysis with 
GDP-β-S failed to inhibit the effects of sigma ligands.  Furthermore, the inability 
of cell dialysis to block the effects of sigma receptors suggests that a diffusible 
cytosolic second messenger is likely not involved. 
 Sigma receptors have been shown to modulate K+ channels in various cell 
types.  Mammalian ICG neurons exhibit currents mediated by delayed outwardly 
rectifying K+ channels (IK(DR)) (Xi-Moy and Dun, 1995; Hogg et al., 1999) and 
express various subunits that contribute to these channels, including KCNA5 and 
KCNA6 (Cuevas, unpublished observation).  In neonatal rat ICG neurons, effects 
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of sigma receptor activation on voltage-dependent K+ channels were studied by 
whole cell patch-clamp techniques under voltage-clamp mode.  Sigma receptor 
activation inhibits multiple K+ channel subtypes in ICG neurons, which include 
K(DR), large conductance Ca2+-activated K (BK), and M channels, with maximal 
inhibition > 80%.  The inhibition on IK(DR)  is dose-dependent and IC50 values for 
(+)-pentazocine, ibogaine and DTG are 76.4, 218 and 341 µM, respectively.  The 
rank order of potency of (+)-pentazocine > ibogaine > DTG suggests that the 
effect is mediated by sigma-1 receptor activation.  The IC50 values for the various 
sigma ligands tested here are in agreement with those reported in the literature 
for modulation of voltage-activated K+ channels.  The inhibitory effect of Ik of DTG 
is blocked by pretreatment with metaphit, an irreversible sigma receptor 
antagonist, which strengthens the observation that sigma receptors mediate the 
effects of DTG on IK in these cells. To determine whether sigma receptor-
mediated inhibition of K+ channels in ICG neurons is dependent on G-protein 
activation, neurons are dialyzed with pipette solution containing either 100 µM 
GTP or 100 µM GDP-β-S.  Intracellular application of GDP-β-S fails to block 
sigma-1 receptor-mediated inhibition of IK(DR).  Thus neither a diffusible cytosolic 
second messenger nor a G-protein couples sigma-1 receptors to IK(DR), which is 
in agreement with the direct protein-protein interaction between sigma-1 
receptors and K+ channels shown by Jackson and colleagues (Lupardus et al., 
2000; Aydar et al., 2002).  Application of sigma ligands depolarizes cell 
membrane of ICG neurons at rest and this effect is thought through the inhibition 
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of M-current which contributes to the resting membrane potential of ICG neurons 
and that inhibition of this channel depolarizes the cells (Cuevas et al., 1997).  In 
presence of sigma ligands, the number of action potentials (AP) fired by ICG 
neurons in response to depolarizing current pulses is decreased and depressed 
neuroexcitability likely results from modulation of IK(DR) by sigma receptors.  In 
addition to decreased AP firing, sigma receptor activation also alters the AP 
configuration by decreasing both the AP overshoot and afterhyperpolarization 
(AHP) and by slowing both the rate of depolarization. These latter effects result in 
the increase in AP duration.  The inhibition of BK currents by sigma ligands 
would account, at least in part, for the increase in AP duration and decrease in 
AHPs 
In ICG neurons, the inhibition of voltage-gated Ca2+ and K+ channels can 
not explain the significant decrease in the amplitude of the first AP overshoot and 
complete block of the firing at higher concentration of sigma ligands.  Effects of 
sigma receptor activation on voltage-gated Na+ channels were investigated in 
these neurons.  The voltage-activated Na+ channel in ICG neurons is TTX-
sensitive, with complete blockade at 300 nM TTX.  Bath application of sigma 
ligands inhibits INa in a reversible dose-dependent manner.  Based on the fact 
that the potency (IC50 values) of blocking Na+ channels is similar as Ca2+ 
channels inhibition by selective sigma-1 and sigma-2 receptor ligands, 
(+)pentazocine (51 µM compared with 61 µM) and ibogaine (31 µM compared 
with 31 µM) (Table 5.1), the inhibition of Na+ channels by sigma ligands is also 
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through sigma-2 receptor activation.  The fast inactivation of Na+, which was 
determined by double-pulse protocol, shifts to more negative potentials in the 
presence of sigma ligand, DTG.  Since the fast inactivation of Na+ channel is 
mainly involved in the current and the peak amplitude of INa, the shifting of the 
steady-state inactivation of Na+ to more negative potential attribute at least in 
part to the inhibition of INa by sigma receptors activation.  One of the effects that 
results from the inhibition of voltage-gated Na+ channels by sigma receptors 
activation is a increase in the threshold of AP generation in response to a 400 ms 
current ramp.  Based on our and other group findings, we believe that in rat ICG 
neurons, the initiation of AP firing in response to current ramp is determined by 
voltage-gated Na+ channels and M-channels.  Since blocking M-channels, which 
opposes depolarizing stimuli, would decrease the threshold of AP firing, the 
increase of threshold (latency) of AP firing is likely through the inhibition of Na+ 
channels. 
The present data show that sigma-2 receptors modulate high-voltage-
gated Ca2+ channels in both neonatal rat SCG and ICG neurons.  In rat ICG 
neurons, sigma ligands have inhibitory effects on various types of K+ channels, 
as well as voltage-gated Na+ channels, mediated by sigma-1 receptor and sigma-
2 receptor activation, respectively.  The net effect of sigma receptor modulation 
of ion channels in ICG neurons is decreased neuroexcitability in these neurons 
suggesting that the activation of sigma receptors in ICG neurons will likely to 
  123
attenuate parasympathetic input to the heart, and consequently, will affect 
cardiovascular function. 
 
Table 5.1 IC50 values of selective sigma-1 receptor agonist, (+)-pentazocine and 
sigma-2 receptor agonist, ibogaine on voltage-gated Ca2+, K+ and Na+ channels. 
 
Drug Ca2+ channel K+ channel Na+ channel 
(+)-Pentazocine 61 µM 76 µM 51 µM 
Ibogaine 31 µM 218 µM 31 µM 
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CONCLUSION 
 
Since sigma receptors were first identified in the central nervous system, 
they have been surrounded with a considerable amount of controversy and 
confusion in their physiological functions.  The distribution of these receptors 
appears ubiquitous, and besides the CNS, they have been shown to be present 
in numerous peripheral tissues.  Furthermore, sigma receptors are found to be a 
distinct pharmacological entity distinguished by their unusually promiscuous 
ability to bind a wide variety of drugs and their unique distribution in subcellular 
fractions.  While sigma receptors have been implicated in a variety of 
physiological and pathological conditions, the cellular function of these receptors 
remains poorly understood. 
Several studies have shown that sigma receptors may be involved in the 
regulation of cardiovascular function.  Cardiac performance is continuously 
modulated by both sympathetic and parasympathetic branches of the autonomic 
nervous system.  With respect to neural control of the heart, rat superior cervical 
ganglia (SCG) contain sympathetic efferent postganglionic neurons, which 
innervate various regions of the heart, and intracardiac ganglia (ICG) form the 
principal final common pathway for autonomic modulation of regional cardiac 
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function (Armour, 1994).  Investigatiing of the effects of sigma receptor activation 
on these neurons will help us understand the function of these receptors in the 
cardiovascular system.  Results reported here using structurally dissimilar sigma 
ligands show that sigma receptor activation inhibits multiple voltage-gated ion 
channels in autonomic neurons. The overall effect of the blocking these channels 
is an inhibition of neuroexcitability in these cells.  These data indicate that 
activation of sigma receptors may block signal transduction through autonomic 
ganglia and onto the heart.  Thus the deleterious cardiac side effects induced by 
recreational drugs (e.g. PCP and cocaine) or clinical drugs (e.g. antipsychotic 
and antidepressants), which have high affinity with sigma receptors, may be due 
to their interaction with sigma receptors in autonomic neurons.  Also the effects 
of sigma receptors on these autonomic neurons suggest that sigma receptors 
may mediate the cardiovascular effects of progesterone, a putative for the 
endogenous sigma ligand. 
The data reported here will not only serve to increase our understanding 
of sigma receptors in the heart, but also on the cellular function of these 
receptors in other tissues and organs.  For example, both subtypes of sigma 
receptors have been found highly expressed in tumor cell lines from various 
human cancer tissues, and some studies demonstrate that sigma ligands 
inhibited the proliferation of tumor cells in vitro (Brent and Pang, 1995; Moody et 
al., 2000; Crawford and Bowen, 2002).  The mechanism(s) underlying the 
inhibitory effect of sigma drugs on tumor cell proliferation has not fully been 
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discerned.  Ion channels are expressed in several cancer cell lines and play an 
important role in metastasis (Fraser et al., 2003; Wonderlin et al., 1996; Wilke et 
al., 1999).  The observations that sigma receptors are overexpressed in tumor 
cells and modulate various voltage-gated ion channels as seen in this report 
provide more evidence to support the potential of sigma ligands as anticancer 
drugs.  In CNS, sigma ligands have been shown to exert neuroprotective effects 
both in vivo and in vitro (Lobner and Lipton 1990; Poignet et al., 1992; Takahashi 
et al., 1996; Lockhart et al., 1995; Kimura et al., 1998 Goyagi et al., 2001;). but 
the mechanisms of this effect are not well known.  The modulations of ion 
channels by sigma receptors may mediate, at least in part, the neuroprotective 
effects of sigma ligands during ischemia. 
The most interesting unresolved questions from the sigma receptors 
research are the mechanism(s) of signal transduction.  Based on the results seen 
in the study of the effect of sigma-1 receptor on K+ channels, Jackson and 
colleagues have elucidated a novel mechanism of cellular signal transduction.  In 
this model, they proposed that in response to excellular signals, sigma receptors 
are capable of modulating ion channels function by interacting either with 
channel proteins or some very closely associated membrane constituent (Aydar 
et al., 2002).  This behavior of sigma receptors can be explained by ‘three-state 
allosteric’ mechanism (Leff et al., 1997).  The model of protein-protein interaction 
could be used to explain the results we show here. First, our data show that 
neither a diffusible cytosolic second messenger nor a G-protein is involved in the 
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modulations of ion channels by sigma receptor ligands.  Second, some of the 
sigma receptor antagonist, such as, BD1063 and BD1047, act as sigma receptor 
agonist in the modulation of ion channels in autonomic neurons.  This 
phenomenon suggests that the cellular effects of sigma ligands depend on the 
effector target.  The conformational changes of sigma receptors in response to 
the ligand binding can cause agonist-like effect or antagonist-like effect, which is 
dependent on the effector targets that are close to sigma receptors in the 
microdomains of the cell membrane.   
In conclusion, our studies of the effects of sigma receptors activation on 
voltage-gated ion channels in rat SCG and ICG neurons not only increase the 
knowledge of sigma receptors in the heart, but also have implications for a broad 
range of physiological and pathophysiological processes, such as cancer and 
stroke. 
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